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Abstract 
   Experiment 1, 83, newly weaned, fall-born crossbred heifer calves were allocated 
randomly to 1 of 3 anthelmintic treatments: 1) control (CON); 2) combination pour-on 
moxidectin and oxfendazole (MO); and 3) long-acting eprinomectin (LAE).  Two preplanned 
orthogonal contrast statements were used: 1) to compare CON to treated cattle; and 2) to 
compare OXF to LAE.  Heifer BW and BCS were greater (P≤0.02) from MO and LAE on d 112, 
140, 154, 168, 182 compared to CON.  Heifer cyclicity, estrous detection, natural service and 
overall pregnancy rates were greater (P≤0.02) for MO and LAE compared to CON.  Cattle fecal 
egg counts (FEC) were greater (P<0.01) for CON compared to treated heifers and greater 
(P<0.01) for LAE compared to MO.  Concentrations of white blood cells, lymphocytes, 
eosinophils, basophils, red blood cells, and platelets were greater (P≤0.02) for CON compared to 
treated heifers. Experiment 2, 90, spring-calving cows were allocated randomly to 1 of 3 
anthelmintic treatments: 1) CON; 2) oxfendazole (OXF); and 3) LAE.  Similar contrast 
statements were utilized.  Cow BW, BCS on d 0, 91, 146, and 228, and pregnancy rate did not 
differ (P>0.20) between CON and treated cows.  Day 14 BCS tended (P=0.07) to be greater for 
CON compared to treated cows.  Also, BCS was greater (P=0.01) and hair coat score was lower 
(P<0.01) for OXF compared to LAE on d 91.  Pregnancy rate tended (P=0.08) to be lower for 
LAE compared with OXF.  Over the duration of the study, cow FEC, concentrations of white 
blood cells and eosinophils were greater (P≤0.04) for CON compared to treated cows.  At 
weaning calves were administered the same anthelmintic treatment as their dams.  Calf BW on d 
417 and 431 were greater (P≤0.03) for treated calves compared to CON. Calf weaning weights 
were lower (P=0.03) for LAE compared to OXF.  Calf FEC and platelets were greater (P≤0.02) 
for CON compared to treated calves.  Carcasses from CON steers had greater (P=0.02) 
  
longissimus area and lower (P=0.02) yield grade compared to carcasses from treated calves.  
Based on these two studies, anthelmintic treatment can improve gain and decrease FEC in 
cow/calf operations. 
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CHAPTER 1.  
LITERATURE REVIEW 
Internal parasites are estimated to cost the U.S. cattle industry over $3 billion annually 
(Bagley et al., 1998). Research has indicated that internal parasite burdens flourish in the 
southern states, which encompass 11.8 million beef cows or approximately 40% of the nation’s 
beef cow inventory (USDA-NASS, 2014).  Parasite burdens have been reported to decrease feed 
intake and alter nutrient utilization (Kunkle et al., 2013).  According to the USDA-APHIS 
(2009), approximately 38% of beef cattle producers do not deworm calves prior to weaning; 
furthermore, approximately 41% of calves are not dewormed at weaning.  Although, many 
weaned calves are not dewormed, the same report indicated that slightly under 60% of 
replacement heifers and cows are not dewormed more than one time a year.  The primary 
objective of this literature review will be to describe the important nematodes affecting cattle, the 
immune response associated with parasitic infections, anthelmintic resistance, and conventional 
anthelmintic efficacies reported in beef cattle operations.  
Trichostrongylus life cycle 
 The general life cycle of Trichostrongylus spps. is similar amongst species; however, 
there is some variation.  Levine (1968) described the general life cycle.  First, adult worms living 
within the infected animal, produce and excrete eggs in feces.  In an oxygen dependent rich 
environment, eggs hatch approximately 1 d after excretion in feces and create what is described 
as a rhabditiform 1st stage larvae.  The 1st stage larvae feed on microorganisms and bacteria 
within the feces.  Next, the 1st stage larvae molts into a 2nd stage larvae in 1 to 2 d.  Following 
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another few days, the 2nd stage molts into a strongyliform, infective  3rd stage larvae, with its 
cuticle unsheathed, but not detached.  After development of the 3rd stage infective larvae, this 
stage migrates out of the feces and moves to vegetation in close proximity to the fecal mat.  On 
vegetation, if ingested by the appropriate host (start of prepatency), the cuticle is detached in the 
gastrointestinal tract, and the infective 3rd stage larvae move to the targeted area within the host.  
Once at the appropriate location, the 3rd stage molts to a 4th stage larvae, then to a 5th stage, and 
lastly into adult.  After it reaches the adult stage, the nematode becomes patent and releases eggs 
and the cycle is perpetuated (Levine, 1968).  
The time from becoming an infective larvae (3rd stage) to adult occurs in various optimal 
temperatures based on the nematode species (Levine, 1968).  Under normal circumstances and 
adequate moisture, temperature plays a crucial role in the ability for eggs to hatch.  For most 
species, temperatures between 20 to 30°C are optimal for effective hatching ability (Ballweber, 
2006).  Once eggs hatch and larvae enter the environment, they are subject to desiccation due to 
extremely low or high temperatures or contact with direct sunlight (Ballweber, 2006).  
Stromberg and Averbeck (1999) indicated that less than 33% of larvae that develop from 
excreted eggs develop into infective larvae, possibly as a result of inadequate conditions for 
development.   
General Trichostrongylus spps. characteristics 
 Trichostrongylus spps. are considered to be small, slender nematodes (Levine, 1968) that 
affect multiple livestock species, including most of the domestic livestock species.  The most 
economical and detrimental parasites that affect small ruminants, cattle, and other animals are 
encompassed in this group (Levine, 1968).  Generally, speaking, this genus is characterized as 
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having a small head that is absent of a buccal cavity and cervical papillae.  Females deposit thin 
shelled eggs that are segmented prior to deposition.  The female vulva is located just behind the 
middle of the body and usually has predominant lips.  In terms of male reproductive parts, the 
male bursa has predominate lateral lobes and a well distinguished, symmetrical dorsal lobe, but 
is absent of accessory bursal membranes.  However, the gubernaculum is present in most cases, 
and the spicules are brown in color, and are considered to be stout, stunted, and uneven (Levine, 
1968).   
Important cattle nematodes and associated pathogensis  
  Ballweber (2006), indicated that the most common parasitic infections in cattle were as a 
result of Cooperia, Haemonchus, Ostertagia, and Trichostrongylus species.  These parasites are 
commonly called the HOT Complex (Ballweber, 2006).  Other genera of interest include 
Bunostomum, Nematodirus, and Oesophagostomum.  
Trichostrongylids are characterized as being the most important and most pathogenic 
nematodes in cattle.  Ostertagia ostertagi (O. ostertagi) and the Cooperia species are of the 
greatest importance and occur most commonly (Levine, 1968).  Pathogenesis of Bunostomum 
phlebotomum (B. phlebotomum) includes, irritation of skin if acquired trans-cutaneously; 
(Sigetwary, 1931), diarrhea, emaciation, anemia, and decreased body weight (BW) (Levine, 
1968).  Cattle with infections of Cooperia species exhibit signs of diarrhea, emaciation, enteritis, 
and ultimately death if the infection continues to perpetuate (Levine, 1968).   
Haemonchus placei (H. placei), is the predominate nematode associated with blood loss 
in cattle.  Levine (1968) reported that H. placei larvae and adults can suck blood from areas 
located on the mucosal lining. Also, H. placei releases an anticoagulant that damages the 
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infected area mucosal lining.  Symptoms associated with H. placei include, decreased weight, 
bottle jaw, anemia, and weakness. 
Andrews and Maldonado (1942) evaluated the pathogenesis of Oesophagostomum 
radiatum (O. radiatum) indicated that cattle are primarily affected during the prepatent period, 
thus indicating pathogenesis is a result of the larvae for this specific gastrointestinal parasite.  
The authors explained that after the initial infection is established, nodules are formed.  These 
nodules are due to inflammation and irritation, and can develop into small abscesses.  Within 
approximately 20 days, the intestinal wall becomes inflamed and edema begins to form where 
the nodules are located (Andrews and Maldonado, 1942).  Other signs of pathogenesis of O. 
radiatum include anorexia (Bremner, 1961), dermatitis if larvae are acquired trans-cutaneously 
(Levine, 1968), emaciation, anemia, weakness, and severe diarrhea (Becklund, 1958).   
Pathogenesis associated with O. ostertagi includes, anemia, edema of the submaxillary 
region, and emaciation (Levine, 1968).  Ostertagia ostertagi is characterized as having three 
“types” of infections.  Type 1 ostertagiasis represents the classical infection, where infected 
animals exhibit, normal signs of pathogenesis (Martin et al., 1957; Anderson et al., 1965).  Pre-
type 2 ostertagiasis is when early 4th stage larvae arrest in the gastrointestinal tract.  However, 
type 2 ostertagiasis occurs when the arrested early 4th stage larvae move out of arrestment and 
continue to mature into adults.  This stage of ostertagiasis normally occurs through the winter 
and spring months in the north but late summer and early fall in the south (Levine, 1968).  
 If present in large abundance, T. axei has been reported to be highly pathogenic 
(Andrews et al., 1954) and can cause decreased performance, such as loss of weight and appetite 
and weakness (Doran, 1955). 
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Immune response during parasitic infections 
Lymphocyte activity: 
Gastrointestinal infections wreak havoc on the animal’s immune system, and the 
mechanisms behind functional immunity still remain unclear (Gasbarre et al., 2001).  Currently, 
it is understood that parasitic infections stimulate either 1 of 2 immune responses, and both are 
characterized as being an antagonistic immune response (Gasbarre et al., 2001).  These immune 
responses are indicative of Th1 or Th2 stimulation.  After stimulation of either one of these two 
immune responses, there is a rise in cytokines that cause stimulation or inhibition of certain 
components of the immune system (Gasbarre et al., 2001).  However, determining if either Th1 
or Th2 is the dominating force behind the immune response, is dependent on which antigen 
presenting cell type is in the greatest quantity, the number of co-stimulatory molecules, and the 
type of cytokine environment (Grencis, 1996; Constant and Bottomly, 1997).  Svetic et al., 
(1993) reported that during times of increased parasitic infections, the Th2 immune response 
elicited high amounts of the cytokine Interleukin 4, IgG1 and IgE antibodies, and mast cells.  
Similar data were reported by Finkelman et al. (1997) and Else and Finkelman (1998) who 
reported that Interleukin 4 and Interleukin-13 promoted protective immunity.  Interferon-γ, 
another cytokine, is up-regulated during times of O. ostertagi infection. 
Cattle infected with O. ostertagi have been reported to have abomasal tissue changes 
post-infection.  Average lymph node size dramatically increases during these infections 
(Gasbarre, 1986, 1994; Canals et al., 1997), and can contribute to an increase in parasite-specific 
lymphocytes or lymphocytes that cannot recognize the antigen associated with the parasite 
(Gasbarre, 1986).  Also, the production of T lymphocytes has been reported to decrease and in 
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return production of B lymphocytes increase in these lymph nodes (Gasbarre, 1994; Canals et al., 
1997).  Interferon-γ is up-regulated during times of O. ostertagi infection due to the increased 
production of lymphocytes (Canals et al., 1997; Almeria et al., 1997) and is indicative of the role 
Th1 and Th2 have on the immune response during times of parasitic infections (Gasbarre et al., 
2001).     
Immunoglobulin production:  
The production of immunoglobulins also play an important role in aiding the immune 
response during parasitic infections. Most of the research evaluating the relationship between 
immunoglobulin production and parasitic infections has been evaluated in infections associated 
with O. ostertagi.  Immunoglobulin E-mediated hypersensitivity has been reported to have a 
direct effect against gastrointestinal protection, in terms of protective mechanisms (Jarret and 
Miller, 1982; Miller, 1996).  Currently, there is little published data reported evaluating the 
effects of IgE production against gastrointestinal nematodes in cattle.  However, conflicting data 
is reported (Baker and Gershwin, 1992; Thatcher et al., 1989; Baker and Gershwin, 1993), 
indicating that IgE mediated responses need to be further evaluated.  In terms of IgA mediated 
responses in naturally- or artificially-infected cattle, O. ostertagi-specific IgA antibodies have 
been reported to increase (Canals and Gasbarre, 1990; Gasbarre et al., 1993).  Frankena (1987), 
reported that IgG2 antibody-containing cells increased during primary and secondary infections 
of O. ostertagi and C. oncophora.  In terms of these primary and secondary parasitic infections 
in calves, IgG2 antibody-containing cells increased in the abomasa mucosa during infections as a 
result of O. ostertagi and in the small intestines as a result of C. oncophora.  Interestingly, 
Kloosterman et al. (1984) reported that high IgG titers were indicative of a lower burden, that 
worms were shorter, and females had less ova/female and had reduced vulval flaps.  With the 
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research presented, it can be suggested that immunoglobulin production plays a crucial role in 
providing a huge impact on the animal’s ability to withstand parasitic infections. 
Eosinophil response: 
Proportions of eosinophils have been reported to increase in both the blood and in the 
intestinal mucosa during parasitic infections (Rothwell, 1989) and can be a direct effect of 
Interleukin-5 production (Korenaga et al., 1994).  The mechanism behind eosinophil’s role in 
protecting cattle against gastrointestinal parasites is still questionable.  With that being said, 
Washburn (1984) reported that O. ostertagi 3rd stage populations are bound to eosinophils, 
although the direct effect of eosinophils on the larvae could not be determined.    
Methods of evading the immune system: 
 Haemonchus placei is a blood sucking parasite that directly impacts the quantity of blood 
in the animal.  Also, in some incidences, H. placei has been reported to inject an anticoagulant 
into the circulatory system which causes greater amounts of blood losses than the parasite could 
actually ingest and utilize for its benefit (Levine, 1968).  
 Ostertagia ostertagi is a parasite that causes elevated, but small lesions on the intestinal 
wall that can cause edema in these locations and in some incidences can cause blood clots on the 
lumen of the stomach (Osborne et al., 1960).  Trelkeld and Johnson (1948) reported decreased 
survival time of red blood cells following the establishment of an O. ostertagi infection. 
 Cooperia species have been reported to cause gross lesions on the duodenum and 
hemorrhages on the intestinal wall, as well as thickening of the intestinal tract mucosa and serosa 
(Bailey, 1949).  Herlich (1965) indicated that C. pectinata evaded the immune system via entry 
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of the small intestines.  It was reported that lesions were reported on the duodenum section of the 
small intestines and can cause lesions and mild inflammation up to 3.65 meters of the duodenum. 
Oesophagostomum radiatum forms small, elevated areas on the walls of the large or 
small intestines.  While these don’t cause much inflammation or irritation, the abscesses 
produced by O. radiatum fill with leukocytes.  Approximately 20 days after the initial signs of 
infection, the intestinal wall that encompasses these abscesses become inflamed and edematous 
(Mayhew, 1948).  Trichostrongylus axei is reported to cause lesions on the abomasum wall that 
in return, cause inflammation, corrugation of the mucosa, sloughing of the epithelium, and 
lymphocytic infiltration (Doran, 1955). 
Anthelmintics  
Anthelmintic therapy is widely used in the livestock industry.  An anthelmintic is a 
pharmaceutical drug that is intended to paralyze or kill parasitic worms in their host (Dictionary, 
2015).  Through many factors, anthelmintic resistance can occur, which allows for the intended 
parasite to survive post-treatment.  Livestock producers commonly associate this problem to the 
small ruminant industry; however, recently anthelmintic resistance has become an increasing 
concern not just locally, but world-wide in cattle.   
 Currently, there are three anthelmintic classes approved for use in cattle.  The first class 
is the imidazothiazole class and includes levamisole; the benzimidazole class is the 2nd and 
includes anthelmintics such as, albendazole (ALB), fendbenazole (FEN), and oxfendazole 
(OXF), and lastly is the macrocyclic lactone class.  This class is divided into two sub-classes: 1) 
1st generation avermectins [ivermectin (IVM), doramectin (DOR), eprinomectin (EPM), and 
abamectin]; and 2) 2nd generation mibemycins [moxidectin (MOX); Edmonds et al., 2010]. 
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Modes of actions 
Imidazothiazoles 
  Treatment against gastrointestinal parasites using imidazothiazoles causes paraylization 
due to the direct cholinergic effect, which is characterized as having effects on the acetylcholine 
receptors of the nematodes’ muscles, where it renders it inactive.  Which in return decreases the 
parasites’ ability to carry out normal function.  Also, the effect on the ganglionic stimulant 
decreases the parasites’ ability to carry out normal processes (Adams, 2001). 
Benzimidazoles 
 Adams (2001) stated that the primary function of this drug class is that it binds to the 
nematode tubulin, specifically to the β-tubulin.  This binding capability prevents the dimerization 
with the α-tubulin, which prevents the polymerization of tubulin oligomers into microtubules.  
Microtubules are directly related to the cellular process, such as mitosis, protein synthesis, and 
energy metabolism.  Preventing the formation of microtubules prevents these cellular processes 
to be carried out.   
Macrocyclic Lactones 
 This drug class affects the nervous system.  They increase the release of γ-aminobutyric 
acid (GABA) from the synapse of the nervous system, which causes the opening of the GABA-
gated chloride channels.  This causes the chloride ions to rapidly enter the cell.  When this 
happens, the cell has decreased resistance, and causes a slight hyperpolarization.  This ultimately 
can cause death or expulsion of the parasite because of the interference of transmission of neural 
stimuli to muscles, which causes flaccid paralysis (Adams, 2001). 
Resistance  
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Resistance is achieved when a fecal egg count reduction (FECR) test are <90%, when the 
anthelmintic is administered at the recommended dose.  Due to the decrease in the development 
of new anthelmintics, resistance is on the rise and is becoming an animal health issue (Barragry, 
1994).  Wolstenholme et al. (2004) describe the 4 possible avenues in which drug resistance can 
occur: 1) change of molecular target; 2) change in metabolism that inactivates, removes, or 
prevents activation of the drug; 3) change in the distribution of the drug that prevents it from 
acquiring the activation site; and 4) amplification of target genes to prevent drug action.  Briefly, 
the mechanism for anthelmintic resistance in the levamisole class can occur when there are 
changes in the receptors associated with nicotinic acetylcholine. Bezimidazole resistance is 
associated with mutations located on the β-tubulin isotype 1 located on the F200Y and F167Y 
genes or through altered metabolism.  Lastly, mutations in either or both the GluCL and GABA-
R genes and the overexpression of P-glycoproteins can lead to macrocyclic lactone drug 
resistance (Wolstenholme et al., 2004).  
Imidazothiazole resistance 
 Parasite resistance is not well documented in the imidazothiazole class.  However, there 
have been reported cases of levamisole resistance in cattle populations.  In one study, Soutello et 
al. (2007), reported minimal cases of levamisole resistance in Argentinian cattle.  Cattle with 
parasite burdens experiencing resistance to levamisole had FECR ranging from 47.4 to 73.7%; 
however, it is important to note, that these cases were not seen in great detail.  In the parasitic 
resistant populations, Cooperia species and H. placei were noted to be resistant to the 
anthelmintic. 
Benzimidazole resistance 
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 Emphasis on evaluating benzimidazole resistance in cattle is not as well evaluated in 
cattle when compared to the macrocyclic lactone class.  However, there have been reports that 
benzimidazole resistance is occurring in cattle productions world-wide.  Fendbendazole has been 
reported to have resistant parasite populations in cattle located in Argentina (Anziani et al., 
2004), Brazil (Mejia et al., 2003), and the United States (Chaudhry et al., 2014).  Soutello et al. 
(2007) reported that cattle populations in Brazil were experiencing parasite resistant populations 
when ALB was administered.   
In one study, Chaudhry et al. (2014) evaluated the prevalence of parasite resistance to 
benzimidazoles.  Adult worm populations were harvested from cattle located on farms across the 
United States.  It was determined that H. placei was becoming resistant to this drug class.  More 
interestingly, it was one of the first studies to report that the mutation located on the β-tubulin 
isotype 1 located on the F200Y was found; however, the polymorphism located on P168 or P167 
was not detected.  The determination of the location of benzimidazole resistance is an important 
find, because it allows for a better understanding of what locations on the gene are aiding in H. 
placei becoming resistant and gives further insight to how the nematode is altering based on 
anthelmintic treatment.  Similarly, H. placei resistance was reported in Argentina (Mejia et al., 
2003; Anziani et al., 2004) and Brazil (Soutello et al., 2007).  Ostertagia species were detected 
to have become resistant to ALB in Brazil (Suarez and Cristel, 2007) and FEN (Mejia et al., 
2003). Several studies have reported a resistant population in Cooperia species (Mejia et al., 
2003; Anaziani et al., 2004; Soutello et al., 2007), following administration of an anthelmintic 
from this class. 
Macrocyclic lactone resistance 
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The macrocyclic lactone class has been reported to be the major concern for anthelmintic 
resistance, with the majority of the research published evaluated this resistance (Kaplan and 
Vidyashankar, 2012).  World-wide resistance has been reported in countries such as, Argentina, 
Brazil, New Zealand, United Kingdom, and the United States (Anziani et al., 2001, 2004; Condi 
et al., 2009; Demeler et al., 2010; Edmonds et al., 2010; Fiel et al., 2001; Mejia et al., 2003).  
Anthelmintics such as IVM and MOX have been reported to have become less efficacious 
(Anziani et al., 2001; Mejia et al., 2003; Anziani et al., 2004; Soutello et al., 2007; Suarez and 
Cristel, 2007; Condi et al., 2009; Gasbarre et al., 2009; Edmonds et al., 2010).  Gasbarre et al. 
(2009) evaluated the efficacy of multiple macrocyclic lactones, such as IVM, EPM, DOR, and 
MOX, and compared them to a negative control (CON) and ALB, using beef calves purchased at 
local sale barns.  It was reported that MOX treated calves had the highest FECR (82%) over 14 d 
and pour-on EPM had the lowest FECR (42%).  Also, IVM- and MOX-treated calves had the 
greatest percentage of worm burdens located in the small intestines.  In a similar study, Anziani 
et al. (2001) reported that IVM-, DOR-, and MOX-treated calves had <90% fecal egg count 
(FEC) following anthelmintic administration.   
Many species of parasites are showing resistance to macrocyclic lactones (Anziani et al., 
2004; Suarez and Cristel, 2007; Condi et al., 2009; Edmonds et al., 2010).  Cooperia species 
have been reported to be resistant to IVM (Fiel et al., 2001; Anziani et al., 2004; Soutello et al., 
2007; Suarez and Cristel, 2007; Edmonds et al., 2010) and MOX (Condi et al., 2009).  
Ivermectin resistance has been shown to be prevalent in the Ostertagia species (Suarez and 
Cristel, 2007; Edmonds et al., 2010) and H. placei (Anziani et al., 2004; Soutello et al., 2007).  
Lastly, cattle treated with MOX have been reported to have resistant populations of 
Oesophagostomum species (Condi et al., 2009).   
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Anthelmintics of interest 
Oxfendazole 
Performance of cattle treated with oxfendazole.  
 Changes in cattle BW have been evaluated after administration of OXF (Chambers, 1985; 
Purvis et al., 1994; Larson, 1995; Ives et al., 2007; Walker et al., 2013), with all of the 
experimental procedures differing a great deal.  Walker et al. (2013) evaluated the effects of 
various anthelmintic treatments consisting of 1) OXF given on d 0 and MOX given on d 73; 2) 
MOX given on d 0 and OXF given on d 73; 3) MOX given on d 0; 4) OXF given on d 0; and 5) 
control (CON).  It was reported that initial and final shrunk BW did not differ across treatments.  
However, control calves had lower ADG compared with treatments 1, 2, and 4; but, did not 
differ from treatment 3.  When evaluating BW on different collection days, it was determined 
that on d 31, treatment 3 had greater BW compared with CON calves.  Next, on 59 days post-
treatment, treatments 1, 2, and 4 had greater BW compared with CON calves, and treatment 3 
was similar to CON calves.  And lastly, 108 days post-treatment the OXF treated caves had the 
greatest BW compared with all other treatments.  In two studies, Chambers (1985) and Larson 
(1995) evaluated the effects of OXF administration with different implants.  First, Chambers 
(1985) evaluated the effects of the administration of zeranol and OXF.  Treatments consisted of: 
1) CON; 2) zeranol; 3) OXF; and 4) the combination of zeranol and OXF application.  It was 
reported that application of either zeranol or OXF increased BW in 8-9 month old calves, with 
7.4 kg, 13.7 kg, and 20.6 kg more BW produced for zeranol-, OXF-, and combination of zeranol 
and OXF-treated calves, respectively, when compared to CON calves.  Larson (1995) evaluated 
the effects of administration of OXF and Synovex-C© on 2-3 mo old calves.  Treatments 
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consisted of 1) CON; 2) OXF administered at 2-3 mo of age and at weaning; 3) implanted with 
Synovex-C© at 2-3 months of age; and 4) dewormed an implanted.  The author reported that 
there was no positive impact on BW and body condition score (BCS) over the duration of the 
study.   
 Additionally, cow reproductive performance has been evaluated in cattle operations.  
Purvis et al. (1994), used 388 mixed breed spring-born heifers to evaluate the effects of 
intrarumminal administration of OXF compared to a negative control.  It was reported that heifer 
age at puberty, first conception and overall pregnancy rates did not differ across treatments.  
Similarly, Larson (1995) determined that there was no effect on heifer cyclicity at the start of the 
breeding season, artificial and overall pregnancy rates, and pre-breeding pelvic area in heifers 
dewormed with OXF, implanted with Synovex-C©, or the combination of the two, compared to 
CON heifers.  
Oxfendazole effects on fecal egg counts and coprocultures 
 Evaluating the effects of oral OXF (Chambers, 1979; Borgsteede and Reid, 1982; Lyons 
et al., 1989; Williams et al., 1997; Walker et al., 2013) or intraruminal injection of OXF 
(Borgsteede et al., 1982; Solcombe et al., 1989; Purvis et al., 1994) has been evaluated in cattle 
operations.  Williams et al. (1997) evaluated the efficacy of pour-on IVM, ALB, OXF, and FEN 
in 10-12 month crossbred heifer calves that were obtained from a local livestock auction barn.  
Cattle had naturally acquired nematode infections at purchase, grazed on pasture for 
approximately 9 wk, and then were moved to concrete floors, where FEC were monitored over a 
28 d period.  It was reported that 3 days post-treatment, cattle receiving the bezimidazole 
treatments had lower FEC compared to IVM pour-on and CON heifers.  Also, by d 7 and 15, all 
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heifers that were administered an anthelmintic had lower FEC compared with CON heifers.  
However, by d 28, IVM pour-on had the lowest FEC compared with other treatments, but the 
benzimidazole treatments still had FEC that were significantly lower than those of the CON 
heifers.  Borgsteede and Reid (1982) used 27 dairy calves that had previously completed their 
first grazing season.  Calves were allocated to 1 of 3 treatments consisting of: 1) CON; 2) oral 
OXF; 3) intraruminal administration of OXF.  Fecal egg counts were monitored for 7 d.  It was 
reported that FEC were lowest in the OXF treatments compared to CON; however, no 
differences were reported between the two routes of OXF administration.   
  In one study, Chambers (1979) evaluated the effects on artificial infections in Friesian 
calves.  Prior to the initiation of study, calves were raised worm-free.  Next, calves were 
administered 10,000 3rd stage O. ostertagi and 10,000 3rd stage C. onocophora at 2, 6, 14, and 24 
days prior to anthelmintic treatment.  Calves were then allocated to either an OXF or CON 
treatment.  The authors reported that anthelmintic treatment of OXF was 76.8% efficacious 
against 3rd to early 4th stage O. ostertagi, and 87.3% efficacious against 4th stage and 98.3% 
efficacious against immature 5th stage and adult O. ostertagi.  Also, it was reported that 
anthelmintic administration of OXF was 99% effective against all stages of C. onocophora.  In 
another study, Solcombe et al. (1989) evaluated the effects of intraruminal administration of 
OXF in either Angus/Simmental or Angus/Hereford calves.  Control calves had lower efficacy 
compared to treated calves.  Angus/Simmental treated calves had a greater reduction in N. 
helvantianus (100%), Strongyloides (83%), and Trichuris (100%) compared to control heifers.  
Next, administration of OXF in the Angus/Hereford calves, had a greater reduction in N. 
helvantianus (100%), Trichuris (100%), and Monieza (100%) compared to heifers that received 
no anthelmintic.  
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Oxfendazole concentrations 
 Moreno et al. (2005) compared the effects of either injectable or oral administration of 
various anthelmintics on milk residues in second lactation Holstein cows.  Treatments consisted 
of: 1) oral OXF; 2) oral ALB; 3) injectable ALB sulphoxide; 4) and injectable OXF, and milk 
was collected for 5 days post-treatment. It was reported that oral OXF reached the greatest 
concentration in the milk at 12 h post-treatment and was detected for up to 72 h.  Also, milk 
residues were detected in the milk for 36 h in the injectable OXF treatment.  Thus, indicating that 
oral administration of OXF created quicker action and lasted longer in milk compared with other 
routes of administration.   
Moxidectin 
Performance of cattle treated with moxidectin 
 Efficacy of MOX has been well evaluated in beef cattle (Williams et al., 1999; Yazwinski 
et al., 1999; Anziani et al., 2001; Elsener et al., 2001; Reinemeyer and Cleale, 2002; Williams 
and DeRosa, 2003; Maritorena-Diez et al., 2005; Ives et al., 2007; Powell et al., 2008; Gomes de 
Soutello et al., 2010; Leathwick and Miller, 2013; Walker et al., 2013; Yazwinski et al., 2013).  
Cattle treated with MOX have been reported to have increased BW (Williams et al., 1999; 
Powell et al., 2008; Walker et al., 2013) and gain performance (Williams et al., 1999; Elsener et 
al., 2001; Powell et al., 2008) over cattle not treated with anthelmintic or in cattle treated with 
IVM (Williams et al., 1999).  In one study, Williams et al. (1999) used seventy-two, 9-12 month 
old, Brangus/Angus, steer calves to determine the effects of pour-on varieties of MOX, DOR, 
IVM, and EPM and compared them to a negative control.  Body weights were taken on d 0, 28, 
56, 84, and 112.  It was reported that treated calves had greater BW and average daily gain 
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(ADG) on d 28, 56, 84, and 112 compared to CON calves.  Also, MOX- treated calves had 
greater BW and ADG compared to IVM-treated cattle on all collection d.  In contrast to the 
previously mentioned study where performance was increased, Ives et al. (2007) evaluated the 
effects of 3 anthelmintics on feedlot performance in auction barn bought mixed-breed steer 
calves.  Treatments consisted of 1) DOR; 2) MOX; and 3) MOX plus OXF.  Calves in this study 
were harvested and carcass measurements were collected.  It was reported that feedlot 
performance, in terms of BW, dry matter intake (DMI), daily gain, and intake:gain ratio were not 
positively impacted by anthelmintic treatment.  Similarly, animal health characteristics, such as 
morbidity and mortality percentages, number of rejects were not significantly reduced in cattle 
receiving anthelmintic treatment compared to CON calves.  Quality and yield grade did not 
differ across treatment groups; however, when MOX was applied with OXF, hot carcass weights 
were greater compared to solely MOX and CON calves.   
Moxidectin effects on fecal egg counts and coprocultures 
 There is a vast array of the effects of MOX on FEC and coprocultures in beef cattle 
(Williams et al., 1999; Yazwinski et al., 1999; Anziani et al., 2001; Elsener et al., 2001; 
Reinemeyer and Cleale, 2002; Maritorena-Diez et al., 2005; Williams and DeRosa, 2003; Ives et 
al., 2007; Powell et al., 2008; Leathwick and Miller, 2013; Gomes de Soutelo et al., 2010; 
Walker et al., 2013; Yazwinski et al., 2013).  Cattle treated with MOX have been reported to 
have lower FEC compared to CON (Williams et al., 1999; Anziani et al., 2001; Elsener et al., 
2001; Maritorena-Diez et al., 2005; Powell et al., 2008; Gomes de Souttello et al., 2010; Walker 
et al., 2013; Yazwinski et al., 2013) and other various anthelmintics (Williams et al., 1999) 
cattle.  As previously mentioned in the paper by Williams et al. (1999), Brangus/Angus steer 
calves were administered topical formulations of MOX, DOR, EPM, and were compared to CON 
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calves.  Seven days post-treatment, MOX-, DOR-, and EPM-treated steer calves had lower FEC 
compared to CON calves.  Also, on d 21 post-treatment MOX had lower FEC compared to 
DOR- and IVM-treated calves, as well as CON cattle.   
 Efficacy of MOX on worm counts varies from study to study.  Yazwinski et al. (1999), 
Reinemeyer and Cleale (2002), Williams and DeRosa (2003), and Yazwinski et al. (2013) 
reported higher efficacy for calves treated with MOX compared with calves receiving no 
anthelmintic. Similar results were reported in cattle treated to IVM (Powell et al., 2008; 
Yazwinski et al., 2013).  Reinemeyer and Cleale (2002) evaluated the effects of pour-on MOX 
and injectable MOX in Holstein calves compared to CON calves.  In this study, the authors 
evaluated the effects of anthelmintic treatment when both larvacial and adultical inoculums were 
experimentally administered.  It was reported that MOX (either pour-on or injectable), was 100% 
efficacious for O. radiatum females and O. radiatum males, 98.6 to 99.2 % for Trichuris species, 
91.8 to 99.0% for Cooperia species, and 95.3 to 96.1% efficacious for Strongyloides papillosus 
(S. papillosus), when larvacial inoculum was administered to Holstein calves.  Similar results 
were reported when adulticidal inoculum were administered to experiment calves.  Treatment 
with MOX reported to be 100% efficacious for O. radiatum females and O. radiatum males, 
100% for female Trichuris species, and 100% for C. onocophora males.  In another study, 
Yazwinski et al. (1999) reported that in lactating dairy cows, the application of MOX pour-on 
was 100% efficacious against Ostertagia lyrata males, C. punctata males, and O. radiatum 4th 
stage larvae and adults.  Also, treated cows had lower populations of Ostertagia species adult 
females, inhibited 4th and developing L4 O. ostertagi adult males, T. axei adults, adult Cooperia 
species females at time of harvest.  Therefore, indicating that MOX is a viable anthelmintic 
against gastrointestinal nematodes. 
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Moxidectin concentrations 
 In one study, Sallovitz et al. (2011) compared the in vitro characteristics of both MOX 
and DOR absorption through the skin of cattle.  Samples were taken from Holstein steer calves 
that were harvested in an abattoir in close proximity to where the study was being conducted.  
Next, the research team applied either DOR or MOX pour-on variations to the skin.  It was 
reported that both anthelmintics passed through the skin for up to 72 h post-treatment.  Also, 
when comparing DOR to MOX, DOR had a longer lag time and higher flux compared with 
MOX. 
 Imperiale et al. (2002) and Imperiale et al. (2009) evaluated the residue effects of 
moxidectin pour-on.  First, Imperiale et al. (2002) evaluated the effects of IVM and MOX in 
whole milk samples.  In this study, drug free milk was fortified with either anthelmintic, and 
abamectin was considered as the standard.  It was reported that MOX had a retention time in the 
milk of 8.5 min, IVM at 8.1 min, and abamectin at 11.6 minutes.  Also, it was determined that 
MOX had a 72% drug recovery in the milk, whereas IVM had 75% drug recovery.  In another 
study, Imperiale et al. (2009), evaluated the effects of preventative allogrooming (for 5 days) 
versus allowed allogroming, on plasma and milk concentrations of MOX in Holstein dairy cows.  
It was reported that in both treatments, concentrations of MOX were recovered from 12 to 15 d 
post-treatment, with lower concentrations in the preventative allogrooming group.  Also, the 
allowed allogrooming group had a shorter time to peak concentration compared with the 
preventative group (3 vs. 7 days, respectively).  However, after the lift on preventative care was 
waived, milk concentrations began to rapidly increase.  Thus indicating, that the standard 
withdrawal period required before slaughter and milk harvesting is valid. 
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Eprinomectin 
A pour-on formulation of EPM is available in a 0.5% solution, which is effective at 0.5 
mg/kg of BW (Kunkle et al., 2013), This formulation has been reported to have positive effects on 
both endoparasites (Shoop et al., 1996; Williams et al., 1999; Cramer et al., 2000; Dorny et al., 
2000; Cringoli et al., 2003; 2004) and ecoparasites (Shoop et al., 1996).  Recently, an alternative 
to the pour-on EPM has been released on the market.  This form of EPM is a long-acting EPM that 
is administered at 1 mg/kg BW subcutaneously (Forbes, 2013; Kunkle et al., 2013).  In this form, 
EPM is incorporated into a poly(D, L-lactide-co-glycolic) acid which allows for it to be slowly 
released in the body (Kunkle et al., 2013; Soll et al., 2013).  Forbes (2013) reported that plasma 
concentrations of eprinomectin in the body increase after delivery of the drug, then gradually 
decline to approximately d 20 and remain at low levels until approximately d 70.  Around d 90, 
the second peak of plasma concentrations increase and remain at these levels until d 120, after 
which they decline until approximately d 150 to160.   
Performance of cattle treated with long acting eprinomectin 
 Long-acting eprinomectin (LAE) treatment has also been reported to increase cattle BW 
over a 120-d grazing period (Kunkle et al., 2013; Rehbein et al., 2013a).  In one study, cattle 
treated with LAE achieved approximately 10 percentage units more live weight gain compared 
to untreated cattle (Kunkle et al., 2013).  
Long-acting eprinomectin effects on fecal egg counts and coprocultures 
Recently, several studies have compared effects of LAE on gastrointestinal parasite 
control vs untreated groups of cattle.  Rehbein et al. (2013b) evaluated the effects of LAE on 
induced infections of developing (4th stage) and adult nematodes.  Cattle were inoculated with 3rd 
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stage larvae or eggs of numerous cattle parasites with the intent that, at time of anthelmintic 
treatment, nematodes were either 4th stage or adults.  Treatments consisted of 1) CON; or 2) 
LAE.  Cattle were monitored for 14 to 22 days over a series of 6 studies.  Therapeutic treatment 
of LAE against developing 4th stage pulmonary and gastrointestinal nematodes resulted in 
significantly lower nematode counts compared to the CON group.  A 99% efficacy of LAE for 
the following nematodes: Dictyocaulus viviparous (D. viviparous), B. phlebotomum, Cooperia 
curticei (C. curticei), C. oncophora, C. surnabada, C. punctata, Haemonchus contortus (H. 
contortus), H. placei, N. helvetianus, O. radiatum, Oeosphagostomum venulosum, Ostertagia 
leptospircularis (O. leptospircularis), O.ostertagi, Ostertagia circumcincta, Ostertagia pinnata, 
Ostertagia trifurcate (O. trifurcate), S. papillosus, T. axei, and Trichostrongylus colubriformis 
(T. colubriformis) was reported.  Also, LAE treated cattle had significantly lower adult nematode 
counts compared with the CON cattle.  Similarly, it has been reported in studies evaluating the 
effects of LAE on naturally infected cattle with pulmonary and gastrointestinal nematodes that 
LAE treatment significantly reduced overall nematode counts and inhibited 4th stage larvae 
(Hunter et al., 2013) and stongylid eggs (Kunkle et al., 2013; Rehbein et al., 2013a).  Thus, LAE 
has substantial effectiveness against most pulmonary and gastrointestinal parasites that affect 
cattle.   
Duration of efficacy of long-acting eprinomectin 
 There is a single manuscript in the current literature determining the length of efficacy of 
LAE on nematode control in cattle.  Soll et al. (2013) in a series of 10 individual studies, 
reported the use of LAE on 198 mixed breed cattle in the United States, United Kingdom, and 
Germany.  In these studies, cattle were allocated to either a control group or an LAE group.  
Cattle were experimentally infected on d 100 (studies 1 & 2) and d 120 (studies 1-8) with 
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variations combinations of H. contortus, H. placei, O. ostertagi/lyrata, O. leptospicularis, 
Ostertagia spps. (ovine), T. axei, T. colubriformis, C. oncophora/surnabada, C. puctata, C. 
curticei, N. helvetianus, B. phlebotomum, O. radiatum, S. papillosus, Trichuris spp. (ovine) 
and/or D. vivipaus or on d 150 with H. contortus, O. ostertagi/lyrata, B. phlebotomum, O. 
radiatum, and D. viviparus.  Studies 1 and 2 reported that LAE treated cattle had fewer C. 
oncophora/surnabada, C. puctata, and T. axei compared to CON.  Long-acting eprinomectin 
treated cattle had fewer nematode counts for H. contortus, O. ostertagi/lyrata, O. leptospicularis, 
T. circumcincta, O. trifurcata, T. axei, C. punctata, B. phlebotomum, O. radiatum, and D. 
viviparus.  Results indicated that cattle challenged at 150 d had fewer H. contortus, B. 
phlebotomum, O. radiatum, and D. viviparus.  In this series of studies, the authors reported that 
treatment of LAE in cattle that were experimentally challenged with a variety of pulmonary and 
gastrointestinal nematodes resulted in a high efficacy rate for a variety of these nematodes, and 
that LAE can control these nematodes for up to 150 d post treatment. 
Due to its long efficacy period and effectiveness, LAE may increase in popularity with 
cattle producers.  However, due to the long-lasting effects of LAE and possible increased in use 
by cattle producers, possible parasitic resistance may occur and further research is warranted to 
determine these affects.   
Conclusion 
 Gastrointestinal parasites cause detrimental effects on the animal’s immune system and 
performance, and can cause huge losses for cattle operations.  Therefore, treatment against 
gastrointestinal parasites is crucial to improving these economic traits and the well-being of 
infected animals.  Lastly, oxfendazole, moxidectin, and long-acting eprinomectin are 
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commercially available anthelmintics that beef cattle producers can implement into their operation 
to mitigate the negative attributes of gastrointestinal parasite infections.   
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Chapter II.  
Effects of moxidectin/oxfendazole combination and long-acting eprinomectin 
administration on post-weaning performance, reproductive measurements, fecal egg 
counts, and complete blood cell counts in fall-born replacement beef heifers 
Abstract 
Huge monetary losses to the United States’ cattle industry are a result of internal 
parasites.   Little current research is available evaluating the effects of anthelmintic treatment in 
replacement beef heifers.  The objective of this study was to evaluate the effects of anthelmintic 
therapy on post-weaning gain performance, reproductive measurements, fecal egg counts (FEC), 
and complete blood cell counts in fall-born Angus and Angus × Hereford replacement heifers.  
Eighty-three, newly weaned, fall-born crossbred heifer calves were stratified by d -14 BW and 
FEC, and d of age and allocated randomly to 1 of 3 anthelmintic treatments: 1) control (n = 28; 
no anthelmintic administered; CON); 2) combination pour-on moxidectin and oxfendazole (n = 
28; MO); and 3) long-acting eprinomectin (n = 27; LAE).  Heifers grazed in individual treatment 
groups on pastures containing endophyte-infected tall fescue, for a 274-d grazing study.  
Anthelmintics were administered on d 0 and 154 of the study.  Two preplanned orthogonal 
contrast statements were utilized and included: 1) to compare CON to treated cows (OXF and 
LAE); and 2) to compare OXF to LAE.  Heifer BW and BCS were greater (P ≤ 0.02) from MO 
and LAE on d 112, 140, 154, 168, 182 compared with CON.  Heifer cyclicity, estrous detection, 
natural service and overall pregnancy rates were greater (P ≤ 0.02) from MO and LAE compared 
with CON.  Cattle FEC over the 274 d study were greater (P < 0.01) from CON compared to 
treated heifers and greater (P < 0.01) from LAE compared to MO.  Concentrations of white 
blood cells, lymphocytes, eosinophils, basophils, red blood cells (RBC), and platelets (PLT) 
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were greater (P ≤ 0.02) from CON compared with treated heifers.  In the current study, 
anthelmintic therapy increased performance and reproductive measurements, decreased FEC and 
the majority of the WBC, as well as RBC, and PLT in fall-born replacement beef heifer calves 
over a 274 d grazing study.  
Introduction 
 Internal parasites are estimated to cost the United States’ cattle industry over $3 billion 
annually (Bagley et al., 1998) and have been reported to flourish in the southern states, which 
incorporates 11.8 million beef cows (40% of total US beef inventory; USDA-NASS, 2014).  
Burdens have been reported to decrease feed intake and alter metabolism (Kunkle et al., 2013).  
According to the USDA-APHIS (2009), approximately 38% of beef cattle producers do not 
deworm calves prior to weaning; furthermore, approximately 41% of calves are not dewormed at 
weaning.  The same report indicated that slightly under 60% of replacement heifers and cows are 
not dewormed more than one time a yr, thus contributing to the monetary loss associated with 
internal parasites.   
 Recently, a long-acting eprinomectin (LAE) has become commercially available for beef 
cattle.  Long-acting eprinomectin is a member of the macrocylic lactone family and is slowly 
released in the body (Kunkle et al., 2013; Soll et al., 2013).  Forbes (2013) outlined the plasma 
concentrations in the body.  Concentrations of LAE in the body increase rapidly after 
administration, then gradually decline to approximately d 20 and remain at low levels until 
roughly d 70.  Around d 90, the second peak of plasma concentrations increase and remain at 
these levels until d 120, after which they decline until d 150-160.  Long-acting eprinomectin has 
been reported to increase animal BW (Kunkle et al., 2013; Rehbein et al., 2013a) and to be 
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efficacious against intestinal parasites (Hunter et al., 2013; Kunkle et al., 2013; Rehbein et al., 
2013a; Rehbein et al., 2013b).  However, LAE has not been well evaluated in replacement beef 
heifers in comparison to other anthelmintics.  Therefore, the objective of this study was to 
evaluate the effects of LAE and a combination of moxidectin/oxfendazole administration on 
post-weaning performance, reproductive measurements, fecal egg counts (FEC), and complete 
blood cells counts (CBC) in fall-born replacement beef heifers.   
Materials and Methods 
This study was conducted at the University of Arkansas’ Stocker Cattle Receiving Unit 
located in Savoy, Arkansas.  All methods and procedures were approved by the University of 
Arkansas’ Institutional Animal Care and Use Committee (approval #14034) prior to the initiation 
of the study.   
Treatment management 
 This study began on June 2, 2014, where 83, newly-weaned, fall-born crossbred heifers 
(Angus or Hereford sired; 225 ± 3.6 kg initial BW) were utilized.  Heifers were processed 14 d 
prior to initiation of the study (weaning) to determine BW and FEC.  Also, at this time heifers 
were branded, administered a clostridial vaccine (Ultrabac7, Zoetis, Florham Park, NJ), as well 
as a respiratory and reproductive vaccine (Virashield 6 + VL5HB, Novartis, Larchwood, IA).  
Cattle were stratified by d -14 BW and FEC, and d of age and then allocated randomly to 1 of 3 
anthelmintic treatments consisting of: 1) control (n = 28; no anthelmintic administered; CON); 
2) a combination of pour-on moxidectin and oral oxfendazole (n = 28; MO; Cydectin/Synanthic 
combination; Boerhringer Ingelheim Vetmedica Inc., Saint Joseph, MO); and 3) long-acting 
eprinomectin (n = 27; LAE; LongRange; Merial Limited, Duluth, GA) and anthelmintic 
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treatments were applied on d 0.  Anthelmintics were given at a recommended dose with 
moxidectin administered topically along the midline of the back (0.5 mg/kg BW) and 
oxfendazole administered orally (4.5 mg/kg BW).  Long-acting eprinomectin was administered 
s.c. (1 mg/50 kg BW) in the neck.  A brucellosis vaccine was administered to all study heifers on 
d 14 of the study (June 16, 2014). 
 Fifty-six days prior to the initiation of the breeding season (d 84) heifers were boostered 
with clostridial, respiratory, and reproductive vaccines.  Respective anthelmintic treatment was 
re-administered to heifers on d 154 of the study (14 d prior to the initiation of the breeding 
season).  On d 158, 10 days before initiation of the breeding season, and on d 168, beginning of 
the breeding season, whole blood was collected via the jugular vein to determine progesterone 
concentrations, which were analyzed using a RIA assay (ImmuChem Coated Tube Progesterone 
RIA Kit; Catalog #07-270102; MP Biomedicals, Solon, OH).  Progesterone concentrations were 
used to determine the percentage of heifers that were considered cyclic, and heifers were 
considered cyclic if progesterone concentrations were ≥ 1 ng/mL, on either collection d (d -10 or 
0 of the breeding season).  On d 168, each heifer was administered 25 mg of PGF2α (Lutalyse; 
Zoetis; Florham Park, NJ) and equipped with an Estrotect patch (Rockway Inc., Spring Valley, 
WI).  Estrous detection was monitored for 10 d, and if estrous was detected via activated 
Estrotect patch, heifers were artificially inseminated (AI) by a single technician within 24 h post-
estrous detection.  Heifers that did not display estrous within 7 d were re-administered 25 mg of 
PGF2α and estrous detection was monitored for 3 d, and if estrous was detected heifers were AI.  
Five days later, 1 fertile bull was placed in each treatment group for a 52-d breeding season.  
Rectal ultrasound was conducted on d 234 following the breeding season to determine AI 
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pregnancy rates and repeated on d 274 of the study to determine natural service (NS) pregnancy 
rates.  
Animal management 
Heifers were offered a corn-gluten supplement daily, at 1% BW and had access to 10.1-
ha pastures that consisted of predominately endophyte-infected tall fescue [Lolium 
arundinaceum (Schreb.) Darybysh] and grazed by individual treatment groups for the duration of 
the study.  When forage became limiting, supplemental hay was offered.  At the end of the 274-d 
grazing period, heifers that were confirmed pregnant were commingled into 1 group and grazed 
on similar pastures on the same farm of origin, until calving. 
Sample collection 
Body weights and BCS (1 = emaciated; 9 = obese; Wagner et al., 1988) were recorded on 
d 0, 14, 28, 84, 112, 140, 154, 168, 182, 234, and 274.  Hair coat scores (1 = slick, short summer 
coat; 5 = full winter hair coat; Gray et al., 2011) were recorded on d 0, 14, 28, and 84.  
Approximately 1 mo prior to the initiation of calving season, heifers were weighed to determine 
pre-calving body weight.  Within 24 h of birth, calves were tagged, tattooed, sex was determined 
(bulls were banded), and weights was recorded.  Also at this time, an udder score was recorded 
for each dam according to the Beef Improvement Federation (BIF; 2010), where udder 
suspension and teat size were determined using a 1 to 9 scale (udder suspension: 1 = very 
pendulous: 9 = very tight and teat size: 1 = very large: 9 = very small).  Under these guidelines, 
udder scores were determined using the weakest quarter and were taken by a single, trained 
observer. 
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Heifer FEC and CBC were taken on d 0, 14, 28, 84, 154, 168, 182, 234, and 274.  Fecal 
egg counts were processed according to the Yazwinksi et al. (1994) method.  Briefly, stronglye 
egg counts were counted and recorded for each animal on each sampling d.  Fecal samples were 
analyzed using a direct centrifugation fecal flotation procedure that allows for high specific 
gravity to concentrate strongyle eggs from 1 g of fecal sample.  Samples were then analyzed to 
determine the amount of strongyle eggs present in the sample and counts were recorded.   Blood 
samples were collected from the jugular vein into determine CBC using a K2 EDTA collection 
blood tube.  Blood cell counts were determined using a Cell-Dyn 3700 SL machine (Abbott 
GmbH & Co., Wiesbaden, Germany).  
Statistical Analyses 
 Performance measurements: Body weights, BCS and HCS, calf birth weights, and udder 
scores were analyzed using PROC MIXED of SAS (SAS Inst. Inc., Cary, NC).  Heifer was 
considered the experimental unit.  Calf sire and calf sex were included in the random statement 
to remove sire variation in calf birth weights.  Two orthogonal contrast statements were used: 1) 
to compare CON to treated heifers; and 2) to compare MO to LAE.  All data are reported as least 
squares means.  
Reproductive measurements: Heifer cyclicity, estrous detection, AI, NS, and overall 
pregnancy rates, and calving rates were analyzed using the GENMOD of SAS.  Heifer was 
considered the experimental unit, and the aforementioned contrast statements were utilized.   
 Fecal egg counts and complete blood cell counts: Fecal egg counts were log transformed 
[Y = log10 (x + 1)] prior to analysis and then were converted and reported as geometric means 
(GM).  Fecal egg counts and CBC were analyzed using PROC MIXED for repeated measures of 
analysis, with heifer considered the experimental unit.  The repeated measurement was sampling 
30 
 
d.  Interactions between sampling d and treatment were included in the original model; however, 
if no interaction was detected (P ≥ 0.10), they were removed from the model and only the main 
effects were reported.  If a treatment × sampling d was detected, the means within a day were 
separated using an F-protected t-test.  The aforementioned contrast statements were utilized for 
FEC and CBC.  All data are reported as least squares means.  Significant differences were 
considered when P ≤ 0.05 and differences referred to as tendencies were those having a P-value 
between 0.05 and 0.10. 
Results and Discussion 
Heifer performance is outlined in Table 1.  Heifer BW did not differ (P ≥ 0.84) between 
treatments on d 0, 14, or 28.  On d 84, heifer BW tended (P = 0.06) to be heavier for MO and 
LAE compared to CON heifers.  On d 112, MO-and LAE-treated heifers had greater (P < 0.01) 
BW compared to CON, furthermore, LAE-treated heifers tended (P = 0.10) to have greater BW 
compared to MO-treated heifers.  Heifer BW on d 140, 154 and 182 were greater (P ≤ 0.01) for 
MO- and LAE-treated heifers compared to CON, and LAE-treated heifers had greater (P = 0.03) 
BW compared to MO-treated heifers.  Long-acting eprinomectin- and MO-treated heifers tended 
(P ≤ 0.08) to be heavier compared to CON; however, LAE-treated heifers were heavier (P ≤ 
0.04) compared to MO-treated heifers on d 168 (start of the breeding season) and 274.  On d 234, 
heifer BW was not different (P = 0.26) between CON and treated heifers; however, LAE-treated 
heifers had greater (P < 0.01) BW compared to MO-treated heifers.  Average daily gain did not 
differ (P ≥ 0.14) amongst treatment groups on d 0 to 14, 112 to 140, 154 to 168, and d 234 to 
274.  Heifer ADG on d 14 to 28 was greater (P < 0.01) for LAE-treated heifers compared to MO-
treated heifers, but did not differ (P = 0.65) between CON and treated heifers.  
Moxidectin/oxfendazole combination and LAE heifers had greater (P ≤ 0.01) ADG compared to 
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CON on d 28 to 84, and overall (d 0 to 274), furthermore, LAE had greater (P ≤ 0.01) ADG 
compared to MO on these sampling d.  Treated heifers had greater (P = 0.03) ADG compared to 
CON heifers, but ADG did not differ (P = 0.62) from LAE- and MO-treated heifers on d 140 to 
154.  Average daily gain was greater (P < 0.01) for CON compared to treated heifers on d 182 to 
234, also ADG was greater (P < 0.01) for LAE-treated heifers compared to MO-treated heifers.  
Lastly, ADG on d 84 to 112, and 168 to 182 was greater (P ≤ 0.03) for treated heifers compared 
to CON; however, ADG did not differ (P ≥ 0.62) between MO and LAE.  Overall ADG was 
greater (P = 0.01) for treated heifers compared to CON heifers; furthermore, overall ADG was 
greater (P < 0.01 for LAE-treated heifers compared to MO-treated heifers. 
Body condition score followed a similar pattern as heifer BW and did not differ (P ≥ 
0.46) on d 0, 14, or 28 across treatments.  Heifer BCS was greater (P ≤ 0.04) for MO- and LAE-
treated heifers compared to CON on d 84, 112, 140, 154, 182, and 234; however, did not differ 
(P ≥ 0.15) between MO and LAE on each respective sampling d.  Body condition score on d 168 
and 274 was greater (P ≤ 0.04) for treated heifers compared to CON heifers and LAE had greater 
(P < 0.01) BCS compared to MO-treated heifers.  Hair coat scores did not differ (P > 0.05) 
across treatments on any sampling d.   Based on this study, heifer BW, BCS, and ADG can be 
improved over a 274-d grazing study, following administration of a combination of pour-on 
moxidectin and oral oxfendazole or long-acting eprinomectin.  Our data agrees with one study 
that utilized seventy-two, 9 to 12 mo old, Brangus/Angus steer calves, and anthelmintic 
treatments consisting of: moxidectin (MXD), doramectin (DOR), ivermectin (IVM), and 
eprinomectin (EPM), and indicated an improvement (P < 0.05) in BW in treated-steers over a 
122-d study compared with CON steers (Williams et al., 1999).  Walker et al. (2013) utilized 
weaned steer and heifer calves to evaluate the effects of 1) oxfendazole (OXF) administered on d 
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0 and MXD on d 73; 2) MXD administered on d 0 and OXF administered on d 73; 3) OXF 
administered on d 0; 4) MXD administered on d 0, and compared them to a negative control.  It 
was reported that final BW did not differ across anthelmintic treatments; however, ADG was 
impacted by anthelmintic administration, with calves receiving combinations of MXD and OXF, 
and OXF on d 0 having improved ADG compared to CON cattle.  Alternatively, Ives et al. 
(2007) reported that administration of MOX in combination with OXF, and MOX alone did not 
improve feed-lot gain performance in mixed-breed steers compared to administration of DOR.  
In one study evaluating the effects of LAE on cattle performance, Kunkle et al. (2013) reported 
cattle BW was increased by approximately 10% in cattle treated with LAE compared to CON 
animals.   
In regards to progesterone concentrations taken on d 158 and 168, fewer (P < 0.01) CON 
heifers were considered cyclic compared with treated heifers (11 vs. 65%, respectively; Table 2).  
Similarly, estrous detection was greater (P < 0.01) for treated heifers compared to CON (43 vs. 
11%, respectively).  Artificial insemination conception rates tended (P = 0.08) to be greater for 
CON compared to treated heifers (100 vs. 46%, respectively).  Lastly, NS (75 vs 44%) and 
overall (80 vs. 50%) conception rates were greater (P ≤ 0.01) for treated heifers compared to 
CON.  Heifer cyclicity (67 vs. 63%), detected estrous (39 vs. 48%), AI conception rates (36 vs. 
54%), and NS conception rates (67 vs. 85%) did not differ (P ≥ 0.15) between MO- and LAE-
treated heifers.  However, overall pregnancy rates tended (P = 0.10) to be greater for LAE-
treated heifers compared to MO-treated heifers (71 vs. 89%, respectively).  Conflicting data has 
been reported evaluating the effects of anthelmintic therapy on reproductive performance.  
Loyacano et al. (2002) and Stromberg et al. (1997) reported that treatment against 
gastrointestinal nematodes can positively impact reproductive performance; while Purvis et al. 
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(1994), Zajac et al. (1991), Ryan et al. (1999), and Larson (1995) reported no advantageous 
effects on reproductive performance post anthelmintic therapy.  Based on the current study, 
improved heifer gain performance, most likely as a result of the decrease in parasitic infections, 
prior to the initiation of the breeding season can positively impact heifer reproductive 
performance as reported by the increase in overall pregnancy rates in long-acting eprinomectin 
and in a combination of pour-on moxidectin and oral oxfendazole compared to control.  It is 
important to note that while AI conception rates tended to be greater for control heifers 
compared with treated heifers, only 3 heifers were artificially inseminated compared to 11 
heifers in the treated groups, thus implying that BW at the beginning of breeding season plays an 
important role in dictating reproductive cyclicity and likelihood of pregnancy in yearling heifers.  
Pre-calving BW did not differ (P = 0.88) between CON and treated heifers; however, LAE-
treated heifers were heavier (P < 0.01) compared to MO-treated heifers, with pre-calving weights 
averaging 431, 414, and 451 kg for CON, MO, and LAE, respectively.  Calving rates (percentage 
of heifers that calved/heifer exposed) were 42, 57, and 81 % for CON, MO, and LAE, 
respectively.  The percentage of heifers that calved were greater (P = 0.01) for treated heifers 
compared to CON heifers; likewise, LAE-treated heifers had a greater (P = 0.04) calving rate 
compared to MO-treated heifers.  Calf birth weights were similar (P = 0.35) across treatments 
and average birth weights ranged from 25 to 27 kg.  Udder suspension tended to be greater (P = 
0.07) from treated heifers compared with CON; however, did not differ (P = 0.45) between MO 
and LAE.  Teat size did not differ (P = 0.36) amongst anthelmintic treatments. 
Over the 274-d grazing season, FEC were greater (P < 0.01) for CON compared to 
treated heifers (Table 3).  Also, MO had lower (P < 0.01) overall FEC compared to LAE (7 vs. 
11, respectively).  A treatment × day interaction was detected (P ≤ 0.05) for FEC, which 
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indicated that CON heifers had the highest FEC on day 28 and 84 of the study compared to all 
other treatment and day combinations, with mean FEC for CON reaching 144 and 164 eggs/g, 
respectively.  Treatment against gastrointestinal parasites has been well evaluated.  Decreased 
FEC following administration of MXD (Williams et al., 1999; Anziani et al., 2001; Elsener et al., 
2001; Maritorena-Diez et al., 2005; Powell et al., 2008; Gomes de Soutello et al., 2010; Walker 
et al., 2013; Yazwinski et al., 2013), OXF (Borgsteede and Reid, 1982; Williams et al., 1997), 
and LAE (Hunter et al., 2013; Kunkle et al., 2013; Rehbein et al., 2013a; 2013b) have been 
reported.  Similar data were reported in the present study, with FEC being drastically reduced for 
treatment of MO and LAE over the 274-d study.  Heifers treated with MO had the lowest FEC 
on d 14 and 168, which implies that approximately 14 d after administration, MO was the most 
efficacious against gastrointestinal nematodes.  As previously mentioned, Forbes (2013) 
evaluated the efficacy length for LAE and determined that on d 150 to 160, plasma 
concentrations of eprinomectin decreased to low levels, indicating that it would no longer be 
efficacious for controlling internal parasites.  In the present study, when evaluating how LAE 
compared to data reported by Forbes (2013), our study agrees with data reported, through the 
first 154 d.  Fecal egg counts decrease to 4, 8, 6, eggs/g on d 14, 28, and 84 post-treatment, and 
then begin to rise on d 154.  Also, on 168, which is 14 d post-anthelmintic treatment (2nd 
administration), fecal egg counts again decrease from 17 eggs/g to 5 eggs/g.  However, on d 182 
(28 d post-treatment) and 234 (81 d post-treatment) FEC increased to 19 and 29 eggs/g, 
respectively.  On d 274 (120 d post-treatment), FEC decreased again to 6 eggs/g suggesting that 
2 consecutive administrations of LAE can lead to different outcomes for FEC in heifers grazing 
on pasture, when compared to data reported by Forbes (2013).  
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The effects of anthelmintic therapy on complete blood counts over the 274-d study are 
outlined in Table 4.  Concentrations of white blood cells (WBC), lymphocytes (LYM), 
eosinophils (EOS), basophils (BAS), red blood cells (RBC), and platelets (PLT) and the 
neutrophil:lymphocyte ratio (N:L) were greater (P ≤ 0.02) for treated cattle compared to CON.  
Also, BAS were greater (P = 0.01) for MO compared to LAE and concentrations of platelets 
were greater (P < 0.01) for LAE compared to MO.  Concentrations of monocytes (MON) and 
neutrophils (NEU) did not differ (P ≥ 0.54) across treatments.  A day effect was detected (P < 
0.01) for WBC, LYM, and MON (Table 5).  White blood cell concentrations were greatest on d 
28 (10.5 K/μL) of the study compared to all other times and lowest on d 154, 168, and 274.  
Lymphocytes were greatest (P < 0.01) on d 0 and 14 compared to all other collection d.  Day 84 
had the least (P < 0.01) concentration of MON compared to other collection days.  A treatment × 
day interaction was detected (P ≤ 0.01) for NEU, with concentrations of NEU being greatest 
from all heifers on d 182, CON and LAE heifers on d 28, and MO-treated heifers on d 0 (Table 
6).  A treatment × day interaction was detected (P < 0.01) for N:L, with all heifers on d 14 
having the lowest ratio compared to all other treatment and d combinations.  Also, a treatment × 
day interaction was detected (P < 0.01) for EOS, with CON heifers having the highest 
concentration of EOS on d 182, 234, and 274.  Basophils also reported a treatment × d 
interaction (P < 0.01), with LAE-treated heifers on d 28 having the greatest concentration of 
BAS compared to all other treatment and d interactions.  Lastly, a PLT treatment × day 
interaction was detected (P < 0.01).  Control and MO heifers had greater proportions of PLT on 
d 28 and CON on d 84.  The differences reported in the CBC, could indicate that the CON 
heifers’ elevated immune response was combating the elevated gastrointestinal parasite 
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infections, with CON heifers exhibiting a greater concentration of most of the white blood cells 
over the 274-d grazing period.   
CONCLUSION 
In conclusion, treatment against gastrointestinal nematode infections in replacement beef 
heifers can improve gain performance and reproductive performance.  Anthelmintic therapy also 
decreased overall FEC in treated heifers, which implies that a combination of pour-on 
moxidectin and oral oxfendazole or long-acting eprinomectin can decrease the overall parasite 
burden over the grazing season.  Body weights and overall conception rates were increased for 
LAE-treated heifers compared to MO-treated heifers.  Therefore, utilization of LAE in 
replacement beef heifers may increase overall herd production. 
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Table 1. Gain Measurements of Fall-Born Heifers Treated With Either Moxidectin/Oxfendazole Combination or Long-
Acting Eprinomectin Over a 274-d Grazing Period 
 Treatmentsa     
Item CON MO LAE SEMb P-Value CON vs 
TREATED 
OXF vs 
LAE 
BW, kg        
d 0 225 225 226 5.4 0.98 0.93 0.90 
d 14 228 228 229 5.4 0.99 0.94 0.91 
d 28 234 233 237 5.3 0.84 0.88 0.57 
d 84 263y 269xy 282x 6.0 0.06 0.08 0.11 
d 112 274f   288ef 302e 6.1 <0.01 <0.01 0.10 
d 140 289g 304fg 322e 6.2 <0.01 <0.01 0.03 
d 154 295f 304ef 324e 6.5 <0.01 0.01 0.03 
d 168 301f 307f 327e 6.8 0.02 0.06 0.04 
d 182 317f 331f 352e 6.8 <0.01 <0.01 0.03 
d 234 354f 349f 378e 7.1 0.01 0.26 <0.01 
d 274 373f 372f 409e 8.4 <0.01 0.08 <0.01 
ADG, kg/d        
d 0 to 14 0.23 0.23 0.22 0.075 0.99 0.93 0.93 
d 14 to 28 0.43ef 0.34f 0.56e 0.065 0.03 0.65 <0.01 
d 28 to 84 0.51g 0.65f 0.81e 0.035 <0.01 <0.01 <0.01 
d 84 to 112 0.39f 0.68e 0.71e 0.044 <0.01 <0.01 0.62 
d 112 to 140 0.54 0.57 0.72 0.074 0.18 0.25 0.14 
d 140 to 154 0.41x 0.00y 0.08y 0.140 0.10 0.03 0.67 
d 154 to 168 0.44 0.21 0.21 0.063 0.60 0.31 0.99 
d 168 to 182 1.15f 1.71e 1.83e 0.191 0.03 <0.01 0.66 
d 182 to 234 0.72e 0.36g 0.51f 0.034 <0.01 <0.01 <0.01 
 3
8
 
Table 1. Gain Measurements of Fall-Born Heifers Treated With Either Moxidectin/Oxfendazole Combination or Long-
Acting Eprinomectin Over a 274-d Grazing Period (Cont.) 
 Treatmentsa     
Item CON MO LAE SEMb P-Value CON vs 
TREATED 
OXF vs 
LAE 
ADG, kg/d        
d 234 to 274 0.46 0.56 0.77 0.110 0.14 0.13 0.18 
Overall 0.54f 0.54f 0.66e 0.021 <0.01 0.01 <0.01 
BCSc        
d 0 5.1 5.1 5.1 0.06 0.99 0.97 0.96 
d 14 5.1 5.2 5.1 0.07 0.46 0.21 0.93 
d 28 5.0 5.0 5.0 -- 1.00 1.00 1.00 
d 84 5.2f 5.4ef 5.5e 0.09 0.03 0.01 0.32 
d 112 5.1y 5.2xy 5.3x 0.07 0.10 0.04 0.43 
d 140 5.6f 5.8ef 5.9e 0.08 0.04 0.02 0.36 
d 154 5.4f 5.6ef 5.7e 0.10 0.05 0.02 0.32 
d 168 5.7f 5.8f 6.3e 0.11 <0.01 <0.01 <0.01 
d 182 5.4f 5.7e 5.9e 0.09 <0.01 <0.01 0.15 
d 234 5.8f 6.0ef 6.3e 0.12 0.02 0.01 0.26 
d 274 5.3f 5.4f 5.8e 0.09 <0.01 0.04 <0.01 
HCSd        
d 0 4 4 4 0.1 0.57 0.92 0.30 
d 14 4 4 4 0.1 0.38 0.17 0.83 
d 28 3 4 3 0.1 0.68 0.41 0.76 
d 84 3 3 3 0.1 0.98 0.74 0.87 
a CON = control; MO = moxidectin/oxfendazole combination; and LAE = long-acting eprinomectin. 
b SEM = pooled SEM.        
c 1 to 9 scale; 1 = emaciated; 9 = obese (Wagner et al., 1988). 
d HCS = hair coat score; 1 to 5 scale; 1 = slick, summer coat; 5 = full winter hair coat (Gray et al., 2011). 
e-g Means within a row without common superscript differ (P ≤ 0.05). 
x-y Means within a row without common superscript tended (P ≤ 0.10) to differ. 
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Table 2. Reproductive Measurements of Fall-Born Beef Heifers Treated With Either Moxidectin/Oxfendazole Combination 
or Long-Acting Eprinomectin Over a 274-d Grazing Period 
 Treatmentsa     
Item CON MO LAE SEMb P- Valuec CON vs 
TREATED 
MO vs 
LAE 
Reproductive performance 
Cyclicity, %d 11 67 63 -- <0.01 <0.01 0.70 
Estrous detection, % 11 39 48 -- <0.01 <0.01 0.50 
AI, % 100 36 54 -- 0.08 0.03 0.39 
NS, %e 44 67 85 -- 0.01 <0.01 0.15 
Overall, %f 50 71 89 -- <0.01 <0.01 0.10 
Pre- and post-calving measurements 
Pre-calving BW, kg 431i 414j 451i 12.7 0.01 0.88 <0.01 
Calving rate, % 93 80 92 -- 0.01 0.01 0.04 
Calf birth weight, kg 25 27 25 1.4 0.35 0.48 0.18 
Udder suspensiong 7 8 8 0.3 0.13 0.07 0.45 
Teat sizeh 7 8 8 0.4 0.36 0.21 0.59 
a CON = control; MO = moxidectin/oxfendazole combination; and LAE = long-acting eprinomectin. 
b SEM = pooled SEM. 
c Reproductive performance and calving rate were analyzed using GENMOD; heifer BW, calf birth weight, udder suspension, and 
teat size were analyzed using PROC MIXED. 
d Cyclicity was achieved if progesterone concentrations were > 1 ng/mL on either d -10 or 0 of the breeding season (d 158 or 168, 
respectively). 
e NS = Natural service pregnancy rate. 
f Overall = Overall pregnancy rate. 
g  1 to 9 scale; 1 = very pendulous; 9 = very tight (BIF, 2010). 
h 1 to 9 scale; 1 = very large; 9 = very small (BIF, 2010). 
i- j Means with a row without common superscript differ (P ≤ 0.05). 
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Table 3. Fecal Egg Count (Geometric Means; GM) Treatment × d Interaction of Fall-Born Beef Heifers Treated With 
Either Moxidectin/Oxfendazole Combination or Long-Acting Eprinomectin Over a 274-d Grazing Period 
 Treatmentsa     
Item CON MO LAE SEMb P-Value CON vs 
TREATED 
MO vs 
LAE 
Overall FEC, GMc 24d 7f 11e 0.0 <0.01 <0.01 <0.01 
d 0 35i 23ij 26ij --    
d 14 67h 1m 4l --    
d 28 144g 5kl 8k --    
d 84 164g 80h 6kl --    
d 154 (re-treat) 15jk 10k 17j --    
d 168 12jk 1m 5kl --    
d 182 7kl 7kl 19ij --    
d 234 6kl 11jk 29ij --    
d 274 6kl 5kl 6k --    
a CON = control; MO = moxidectin/oxfendazole combination; and LAE = long-acting eprinomectin. 
b SEM = pooled SEM. 
c FEC = fecal egg counts. 
d-f Means within a row without common superscript differ (P ≤ 0.05). 
g-m Means without common superscript differ (P < 0.05). 
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Table 4. Blood Cell Parameters of Fall-Born Beef Heifers Treated With Either Moxidectin/Oxfendazole Combination or 
Long-Acting Eprinomectin Over a 274-d Grazing Period 
 Treatmentsa     
Item CON MO LAE SEMb P-Value CON vs 
TREATED 
MO vs 
LAE 
White blood cells K/µL 10c 9d 9d 0.5 <0.01 <0.01 0.69 
Neutrophils, K/µL 2.4 2.4 2.5 0.07 0.54 0.42 0.44 
Lymphocytes, K/µL 6.2c 5.5d 5.4d 0.20 <0.01 <0.01 0.69 
Neutrophil:Lymphocyte 0.45d 0.51c 0.53c 0.018 <0.01 <0.01 0.42 
Monocytes, K/µL 1.02 1.02 0.99 0.028 0.64 0.67 0.40 
Eosinophils, K/µL 0.21c 0.10d 0.07d 0.012 <0.01 <0.01 0.15 
Basophils, K/µL 0.12c 0.11c 0.09d 0.007 <0.01 <0.01 0.01 
RBC, M/µL 8.87c 8.69d 8.75cd 0.05 0.02 0.01 0.33 
Platelets, K/µL 445c 414d 417cd 10.8 0.08 <0.01 <0.01 
a CON = control; MO = moxidectin/oxfendazole combination; and LAE = long-acting eprinomectin. 
b SEM = pooled SEM. 
c-d Means within a row without common superscript differ (P ≤ 0.05). 
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Table 5. White Blood Cell Count Time Effect of Fall-Born Beef Heifers Treated With Either 
Moxidectin/Oxfendazole Combination or Long-Acting Eprinomectin Over a 274-d Grazing Period 
  Datea   
Item 0 14 28 84 154 168 182 234 274 SEMb 
WBC, K/µLc 10.29fg 9.69g 10.50f 9.35g 8.57h 8.40h 10.46fg 9.72g 7.85h 0.271 
LYM, K/µLd 6.5fg 6.9f 6.2g 5.7gh 4.9h 4.5h 5.6gh 6.0g 5.1h 0.23 
MON, K/µLe 1.03fg 1.04fg 1.06fg 0.86h 1.09fg 1.16f 1.05fg 1.00g 0.79h 0.049 
a White blood cell parameters were estimated on d 0, 14, 28, 84, 154, 168, 182, 234, 274 of the study.  
b SEM = pooled SEM. 
c WBC = white blood cells.  
d LYM = lymphocytes.  
e MON = monocytes. 
f-h Means within a row without common superscript differ (P ≤ 0.05). 
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Table 6. Treatment × d Interaction on Complete Blood Cell Counts of Fall-Born Beef 
Heifers Treated With Either Moxidectin/Oxfendazole Combination or Long-Acting 
Eprinomectin Over a 274-d Grazing Period 
 Treatmentsa 
Item CON MO LAE 
Neutrophils, K/µL    
d 0 2.2ed 3.1bc 2.4d 
d 14 1.4e 1.8e 1.7e 
d 28 3.2bc 2.9c 3.1bc 
d 84 2.6cd 2.7cd 2.7cd 
d 154 2.5cd 2.4d 2.2de 
d 168 2.0de 2.5cd 2.7c 
d 182 3.5b 3.2bc 3.5b 
d 234 2.4d 2.1de 2.5cd 
d 274 1.8e 1.3e 1.7e 
Neutrophil:Lymphocyte    
d 0 0.39d 0.58bc 0.48cd 
d 14 0.21e 0.35de 0.31de 
d 28 0.51cd 0.50cd 0.56c 
d 84 0.47cd 0.50cd 0.51cd 
d 154 0.50cd 0.66bc 0.51cd 
d 168 0.44cd 0.67bc 0.71b 
d 182 0.67bc 0.63bc 0.69bc 
d 234 0.44cd 0.37d 0.63bc 
d 274 0.43cd 0.37d 0.41cd 
Eosinophils, K/µL    
d 0 0.13de 0.05e 0.09e 
d 14 0.09e 0.05e 0.03e 
d 28 0.06e 0.02e 0.02e 
d 84 0.10de 0.08e 0.05e 
d 154 0.17cd 0.10de 0.05e 
d 168 0.24cd 0.06e 0.08e 
d 182 0.36b 0.15de 0.10de 
d 234 0.44b 0.16d 0.06e 
d 274 0.37b 0.25c 0.22cd 
Basophils, K/µL    
d 0 0.102ef 0.131e 0.088ef 
d 14 0.116ef 0.066f 0.072ef 
d 28 0.067f 0.065f 0.549b 
d 84 0.054f 0.051f 0.054f 
d 154 0.096ef 0.132de 0.076ef 
d 168 0.387c 0.243d 0.189d 
d 182 0.097ef 0.085ef 0.080ef 
d 234 0.109ef 0.111ef 0.081ef 
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Table 6. Treatment × Day Interaction on Complete Blood Cell Counts of Fall-Born Beef 
Heifers Treated With Either Moxidectin/Oxfendazole Combination or Long-Acting 
Eprinomectin Over a 274-d Grazing Period (Cont.) 
 Treatmentsa 
Item CON MO LAE 
d 274 0.082ef 0.111ef 0.071f 
Platelets, K/µL    
d 0 493de 527d 551d 
d 14 429e 516d 540d 
d 28 732b 711bc 623cd 
d 84 655bc 643c 546d 
d 154 377e 211fg 360ef 
d 168 287f 207fg 245fg 
d 182 519d 475de 474de 
d 234 269f 245fg 256fg 
d 274 245fg 191g 163g 
a CON = control; MO = moxidectin/oxfendazole combination; and LAE = long-acting 
eprinomectin. 
b-g Means without common superscript differ (P ≤ 0.05). 
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Chapter III 
Evaluation of oxfendazole and long-acting eprinomectin administration on gain and 
reproductive performance, fecal egg counts, and complete blood cell counts in spring-
calving cows and their calves 
Abstract 
Cattle performance, feed intake and utilization, and reproductive performance can be 
decreased as a result of gastrointestinal nematode infections; however, current research is limited 
in regard evaluating the effects of various anthelmintic regimens in spring-calving cow 
operations.  The objective of this study was to evaluate the effects of various anthelmintics 
administered to spring-calving cows and their calves on gain and reproductive performance, 
fecal egg counts (FEC), and complete blood cell counts.  Ninety, spring-calving cows were 
allocated randomly to 1 of 3 anthelmintic treatments consisting of: 1) control (n = 30; no 
anthelmintic administered; CON); 2) oral oxfendazole (n = 30; OXF); and 3) long-acting 
eprinomectin (n = 30; LAE), and received treatment prior to calving.  Cows and their calves 
rotationally grazed in individual treatment groups until weaning.  At weaning and on d 417, 
calves were administered the same anthelmintic treatment as their dams and grazed by individual 
groups for 203 d, after which they were separated by sex.  Heifers remained on the farm of origin 
and steers were transported to West Texas A & M Research Feedlot.  Animal was considered the 
experimental unit and two preplanned orthogonal contrast was used: 1) to compared CON 
totreated cattle; and 2) to compare OXF to LAE.  Cow BW, BCS on d 0, 91, 146, and 228, and 
pregnancy rate did not differ (P ≥ 0.20) between CON and treated cows. Day 14 BCS tended (P 
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= 0.07) to be greater for CON compared to treated cows.  Also, BCS was greater (P = 0.01) and 
HCS was lower (P < 0.01) for OXF compared to LAE on d 91.  Pregnancy rate tended (P = 0.08) 
to be lower for LAE compared to OXF.  Over the duration of the study, cow FEC, white blood 
cells and eosinophils were greater (P ≤ 0.04) for CON compared to treated cows.  Calf BW on d 
417 and 431 and were greater (P ≤ 0.03) for treated calves compared to CON calves.  Calf 
weaning weights were lower (P = 0.03) for LAE compared to OXF.  Calf FEC and platelets were 
greater (P ≤ 0.02) for CON compared to treated calves.  Heifer reproductive performance did not 
differ (P = 0.50) amongst treatments.  Carcasses from CON steers had greater (P = 0.02) 
longissimus area and lower (P = 0.02) yield grade compared to carcasses from treated calves.  
Therefore, in this study, anthelmintic administration did not increase cow performance or steer 
carcass measurements but did improve calf post-weaning gain performance. 
Introduction 
Lawrence and Ibarbura (2009) evaluated the economic effects of gastrointestinal 
nematode control in beef cattle and reported that there was a 34% decrease in the break-even 
price for cattle that did not receive anthelmintic treatment.  This decrease in monetary worth was 
valued at $165/hd.  Also, Bagley et al. (1998) reported that gastrointestinal nematode infections 
can cost the United States’ cattle industry approximately $3 billion annually.  Decreases in gain 
performance (Chambers, 1985; Kunkle et al., 2013; Perry and Randolph, 1999; Purvis et al., 
1994; Rehbein et al., 2013a; Walker et al., 2013; Williams et al., 1997; Williams et al., 1999) and 
lowered feed intake and nutrient utilization (Kunkle et al., 2013), as well as poor reproductive 
performance (Loyacano et al., 2002; Stromberg et al., 1997) have been reported when 
anthelmintic administration has not been utilized.     
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 Recently, a long-acting eprinomectin (LAE) has become commercially available for beef 
cattle to control gastrointestinal nematode infections.  The drug is a member of the macrocylic 
lactone family, and Soll et al. (2013) and Forbes (2013) indicated that LAE is slowly released in 
the body which can control gastrointestinal nematode infections for up to 150 to 160 d.   Little 
research is published evaluating the effects of LAE on performance and fecal egg count 
reductions in beef cattle; however, improved cattle performance (Kunkle et al., 2013; Rehbein et 
al., 2013a) and parasite control (Forbes, 2013; Hunter et al., 2013; Kunkle et al., 2013; Rehbein 
et al., 2013a; Rehbein et al., 2013b; Soll et al., 2013) have been reported.  However, the effects 
of LAE compared to other conventional anthelmintics have not been well evaluated.  Therefore, 
the objective of this study was to evaluate the effects of LAE compared to oxfendazole on gain 
and reproductive performance, fecal egg counts, and complete blood cell counts in spring-
calving cows and their calves.   
Materials and Methods 
This study took place at the University of Arkansas-Division of Agriculture Livestock 
and Forestry Research Station, located in Batesville, Arkansas and West Texas A & M 
University, located in Canyon, Texas.  Prior to the initiation of the study, all methods and 
procedures were approved by the University of Arkansas’ Institutional Animal Care and Use 
Committee (approval #14023).  
Treatment management 
 On January 8, 2014, Charlois × Hereford, spring-calving cows (n = 90; 563 ± 8.1 kg BW) 
were processed to determine BW, BCS, and fecal egg count (FEC).  Cows were stratified by 
BW, BCS, and FEC and were allocated randomly to 1 of 3 anthelmintic treatments consisting of: 
1) control (n = 30; CON; no anthelmintic); 2) oral oxfendazole (n = 30; OXF; Synanthic; 
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Boehringer Ingleheim Vetmedica, Inc. Saint Joseph, MO); and 3) long-acting eprinomectin (n = 
30; LAE; LongRange; Merial Limited, Duluth, GA), on February 13, 2014 (d 0; 4 d before the 
initiation of calving season).  Anthelmintics were administered on d 0, at the labeled dose with 
OXF administered orally (4.5 mg/kg BW) and LAE administered s.c (1 mg/50 kg BW) in the 
neck to respective cows.  At this time, a clostridial vaccine (Ultrabac 7, Zoetis, Florham Park, 
NJ) was administered. 
Animal Management  
Cow management 
Cows and their calves rotationally grazed by individual treatment groups on 2.4-ha mixed 
grass pastures, consisting of predominately endophyte-infected tall fescue [Lolium arundinaceum 
(Schreb.) Darybysh; E+], in groups of 14 or 15 pairs, from February to October.  During the 
calving season (February to April) cattle were supplemented with soyhull pellets 2.7 kg/d.  
Calves born to dams on study were processed near birth to determine birth weight, sex (bulls 
were surgically castrated), and all calves were tagged and tattooed.  On d 71, prior to the 
initiation of the breeding season (April, 25, 2014) cattle were administered a reproductive and 
respiratory vaccine (Pyramind 10; Boehringer Ingleheim Vetmedica, Inc.).  Beginning on d 91 
(May 15, 2014), one fertile bull was placed in each group of animals for a 60-d breeding season.  
Cows were processed on d 228 to determine pregnancy by collecting serum from each cow.  
Serum was placed on ice and shipped for pregnancy determination (BioPryn; Moscow, ID). 
Cow sample collection 
 Cow BW, BCS, FEC and complete blood cell counts (CBC) were taken on d 0, 14, 91, 
146, and 203 of the study.  Cattle BCS was determined using the protocol outlined by Wagner et 
al. (1988; 1 = emaciated; 9 = obese).  Hair coat shedding scores (HCS) were evaluated and 
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determined on d 0, 91, and 146 of the study according to the Gray et al. (2011) protocol, which is 
a 1 to 5 scale, where 1 = slick, short, summer hair coat and 5 = full winter coat. Fecal egg counts 
were processed according to the Yazwinski et al. (1994) method.  For CBC, approximately 6 mL 
of whole blood was collected from the jugular vein into a vacuum collection tube containing K2 
EDTA, and were evaluated using a Cell-Dyn 3700 SL machine (Abbott GmbH & Co., 
Wiesbaden, Germany).   
Calf management 
 Prior to weaning, calves were administered a respiratory vaccine (Virashield 6; Elanco, 
Greenfield, IN) and were revaccinated at weaning.  On d 228 (weaning), calves were fenceline 
weaned over a 14-d weaning period, in respective dam treatment groups, on E+ based pastures.  
At weaning, calves were administered a labeled dose of the same anthelmintic treatment as their 
dams.  Following the weaning period, calves grazed on dormant bermudagrass (Cynodon 
dactylon).  Following the grazing phase on bermudagrass, cattle were moved to E+ pastures, and 
remained on respect pastures for the duration of the study.  On d 417, calves were re-
administered their respective anthelmintic treatment, again at a recommended dose.  Calves were 
separated by sex on d 431. Heifers grazed in individual treatment groups from this point further.  
Steers were commingled into one group for 48 d and were shipped to the West Texas A & M 
Research Feedlot, located in Canyon, Texas. 
Calf Samples collection 
 Heifers and steers were processed on d 146, 228 (weaning), 242, 327, 417 (retreat), and 
431 to determine BW, BCS and FEC.  Hair coat scores were evaluated on d 417 and 431.  Whole 
blood was collected to determine CBC from each calf on d 228, 242, 327, and 417 of the study.    
Heifer management 
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 On d 431, heifers were administered a respiratory and reproductive vaccine (Virashield 6 
+VL 5).  Beginning May 15, 2015 (d 456), one fertile bull was placed in each treatment group of 
heifers for a 59-d breeding season.  Following the breeding season, cattle were processed (d 522) 
to determine post-breeding BW, BCS, FEC, and CBC.  Heifers were processed on d 559 to 
determine BW and whole blood was collected to determine pregnancy rate.  At calving, calves 
were processed to determine birth weights, sex (bulls were surgically castrated), and all calves 
were tagged and tattooed. 
Steer management 
 Upon arrival at the West Texas A & M Research Feedlot, steers were divided into a light 
and heavy block within each anthelmintic treatment.  Steers were fed a common feedlot ration 
and bunks were evaluated daily to determine feed allowances using the slick bunk method.  
Within block, once visual estimation of backfat thickness, approximately 1.27 cm, was 
determined, cattle were transported to Amarillo, Texas (Tyson Fresh Meats, Inc.) for harvest.  
Upon harvest, carcass measurements were determined by a trained observer located at the meat 
processing plant.   
Statistical analyses  
 Performance measurements:  Body weights, BCS, HCS, calf birth weights, and carcass 
measurements were analyzed using PROC MIXED of SAS (SAS Inst. Inc., Cary, NC), with 
animal being the experimental unit.  To remove variation in cow performance, calving date was 
included in the random statement to insure that differences reported were not as a result of cows 
calving at different times.  Calf sex and sire were included in the random statement when 
analyzing calf birth weights to remove variation between calf sex and sire.  Carcass quality grade 
was analyzed using PROC GENMOD.  Two preplanned orthogonal contrast statements were 
51 
 
utilized and included: 1) to compared CON to treated cows (OXF and LAE); and 2) to compare 
OXF to LAE.  All treatment means were reported as least squares means.   
 Reproductive measurements: Calving rates, from both cows and heifers, were analyzed 
using PROC GENMOD with animal being considered as the experimental unit. The previously 
mentioned orthogonal contrast statements were utilized to evaluate differences.   
 Fecal egg counts and complete blood cell counts:  Prior to analysis, FEC were log 
transformed [Y = log10 (x + 1)] and reported as geometric means (GM).  Fecal egg counts and 
CBC were analyzed using PROC MIXED for repeated measures of analysis.  Sampling day was 
considered the repeated measure and animal was considered the experimental unit.  Interactions 
between treatment and sampling day were included in the original model; however, if no 
interaction was detected (P ≥ 0.10), they were removed from the model and only effects of 
treatment were reported.  If a treatment × sampling day interaction was detected, means were 
separated using an F-protected t-test.  The aforementioned contrast statements were utilized to 
evaluate differences.  All data are reported as least squares means.  Differences reported as 
significant are those exhibiting P ≤ 0.05 and tendencies exhibited P-values between 0.05 and 
0.10.   
Results and Discussion 
Cow performance, fecal egg counts, and complete blood cell counts  
Eight cows were removed from study due to lack of calving (3 from CON; 3 from OXF, 
and 2 from LAE), therefore, data presented will account for 82 cows.  Cow performance over the 
228 d grazing period is outlined in Table 7.  Spring-calving cow BW on d 0, 91, 146, and 228 did 
not differ (P ≥ 0.20) across anthelmintic regimes, with cow BW on d 228 being 567, 574, and 
572 kg, for CON, OXF, and LAE, respectively.  However, BW tended (P = 0.07) to be greater 
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for CON cows compared to OXF- and LAE-treated cows, on d 14.  Total gain over the duration 
of the study tended (P = 0.07) to be greater for OXF- and LAE-treated cows compared to CON 
cows, but did not differ (P = 0.54) amongst OXF and LAE.   Also, ADG was greater (P = 0.05) 
for CON on d 0 to 14 compared to treated cows; however, ADG tended (P = 0.09) to be greater 
for treated cows compared to CON on d 14 to 91.  Long-acting eprinomectin-treated cow ADG 
tended (P = 0.08) to be lower on d 14 to 91 compared to OXF-treated cows.  Average daily gain 
was greater (P < 0.01) for LAE-treated cows compared to OXF-treated cows on d 91 to 146; 
however, ADG was similar (P = 0.75) between CON and treated cows.  Also, ADG on d 146 to 
228 was greater (P < 0.01) for treated cows compared to CON, but did not differ (P = 0.38) 
between OXF- and LAE-treated cows.  Lastly, overall ADG (d 0 to 228) tended (P = 0.07) to be 
greater for treated cows compared to CON.   
Body condition scores followed a similar pattern as cow BW, where BCS did not differ 
(P ≥ 0.36) amongst anthelmintic treatments on d 0, 146, and 228.  However, BCS tended (P = 
0.10) to be greater for OXF-treated cows compared to LAE-treated cows, but did not differ (P = 
0.96) between treated cows compared to CON cows on d 14 of the study.  Finally, cow BCS on d 
91 was greater (P = 0.01) for OXF compared to LAE; however, did not differ (P = 0.96) for 
CON compared to treated cows.  This study disagrees with previous research reported by Kunkle 
et al. (2013) and Rehbein et al. (2013a) which evaluated cattle of various ages and stages of 
production and reported that BW was increased during the grazing season compared with the 
negative control.  While there were improvements reported in terms of BW, ADG, and BCS 
throughout the study, it is important to keep in mind that BW and BCS were not improved at the 
end of the study period for the cows, which conflicts with other data reported.  Cow HCS on d 0 
(February 13) and 146 (July 9) did not differ (P ≥ 0.61) amongst treatments.  However, HCS on 
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d 91 was lower (P < 0.01) for OXF-treated cows compared to LAE-treated cows, but did not 
differ (P = 0.39) between CON and treated cows.  As to be expected, cattle HCS decreased by 
May overall.  The improvement in BCS reported in the OXF-treated cows, may have been a 
result of the decrease in HCS.  
 Cow conception rates in the subsequent breeding season (May to July), did not differ (P 
= 0.59) for CON cows compared to treated cows; however, conception rates tended (P = 0.08) to 
be greater for OXF compared to LAE cows.  Conception rates were 77, 81, and 61%, for CON, 
OXF, and LAE respectively.  Conception rates reported agree with previous work outlined by 
Larson (1995), which reported that conception rates were not increased in cattle administered 
intrarumminal of OXF compared to control cattle.  It is important to remember that cows in this 
present study were rotated through pastures that consisted of predominately E+.  In a study 
where similar pastures were grazed, Caldwell et al. (2013) reported that calving rates from spring 
calving cows were 44 and 80%, for cattle with full vs limited access to E+, respectively.  
Although, LAE tended to have lower conception rates compared to OXF-treated cattle, they were 
all greater compared to cattle with complete access to E+ reported by Caldwell et al. (2013) and 
OXF-treated and CON cow conception rates were similar to that of those with limited access to 
E+.   
Effects of anthelmintic treatment on FEC over the 228 d grazing study are described in 
Table 8.  Fecal egg counts for the duration of the grazing period were greatest (P < 0.01) for 
CON compared ti treated cows.  Also, FEC were greater (P < 0.01) for LAE-treated cows 
compared to OXF-treated cows over the duration of the grazing period.  Cow mean FEC 
averages were 2.4, 1.5, and 2.1, eggs/g for CON, OXF, and LAE, respectively.  While 
differences arose from anthelmintic therapy, mean FEC remained low for the duration of the 
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study, which may have been due in part to the cows on a rotational grazing program.  Allowing 
the cattle to be moved to fresh pasture when forage became limiting, can decrease a cow’s 
opportunity to acquire infective 3rd stage larvae.  A treatment × day interaction (P < 0.01) was 
detected for FEC.  Fecal egg counts were the greatest on d 228 for LAE compared to all other 
treatment and d combinations.  As to be expected, FEC was the lowest on d 14 for OXF- and 
LAE-treated cows and on d 91 for OXF-treated cows, with mean FEC averaging 1.0, 1.2, and 
1.1, eggs/g respectively.  Forbes (2013) outlined the duration of efficacy for LAE.  It was 
reported that LAE increases rapidly post-administration and decreases to low levels around d 25 
and remains at these levels until approximately d 70.  On approximately d 90, plasma 
concentrations of LAE being to rise resulting in a second peak, which remains at these levels 
until d 120.  After d 120, plasma concentrations begin to decrease through d 150 to 160.  In the 
present study, LAE-treated cows exhibited a decrease in FEC until d 146 mimicking the duration 
of efficacy length reported by Forbes (2013).  However, by 228, FEC exhibited by cows treated 
with LAE had increased to their highest levels throughout the study for all treatment and 
sampling day combinations.  Data from the current study agrees with previous work completed 
that reported FEC was decreased in cattle treated with OXF (Chalmers, 1979; Borgsteede and 
Reid, 1982; Williams et al., 1997; Walker et al., 2013) compared to cattle that were not treated 
with an anthelmintic. 
 Effect of anthelmintic therapy on CBC over the 228 d grazing period is outlined in Table 
9.  Concentrations of white blood cells (WBC) were greater (P = 0.04) for CON compared to 
treated cows, furthermore, WBC were greater (P < 0.01) for OXF-treated cows compared to 
LAE-treated cows.  Long-acting epriomectin-cows had greater (P = 0.02) concentration of 
neutrophils (NEU) compared to OXF; however, NEU did not differ (P = 0.67) from treated cows 
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compared to CON cows.  Lymphocytes (LYM) tended (P = 0.08) to be greater for CON cows 
compared to treated cows, also, OXF had greater (P < 0.01) LYM compared to LAE.  Inversely, 
the neutrophil:lymphocyte ratio (N:L) tended (P = 0.06) to be greater for treated cows compared 
to CON cows, and likewise, LAE had a lower N:L (P < 0.01) compared to OXF.  Control cows 
had greater (P = 0.01) eosinophils (EOS) compared to treated; furthermore, EOS were greater (P 
< 0.01) for OXF compared to LAE.  Differences reported for EOS could be as a result of the 
increase in parasitism depicted by FEC, which may indicate that EOS were trying combat the 
parasitic infections reported.  Eosinophils are characterized as being activated during the late-
phase of an inflammatory response (Abbas et al., 2015).  Concentration of basophils (BAS) did 
not differ (P = 0.83) for CON compared to treated; however, BAS tended (P = 0.06) to be greater 
from OXF compared to LAE.  Concentrations of monocytes (MON), red blood cells (RBC), and 
platelets (PLT) did not differ (P ≥ 0.30) amongst treatments.  A treatment × day interaction was 
detected (P = 0.03) for WBC, where all treatments on d 14 and CON on d 0 had the greatest 
concentration of WBC (Table 10).  Also, CON, OXF, and LAE on d 0 and 146, as well as LAE-
treated cows on d 91 had the greatest concentration of NEU, as depicted by the treatment × day 
interaction (P < 0.01).   Long-acting eprinomectin-treated cows had the greatest N:L on d 91 
compared to all other treatment and sampling day combinations (treatment × day interaction; P < 
0.01).  Lastly, a treatment × day interaction was detected (P < 0.01) for concentrations of EOS, 
were OXF-treated on d 91 had a greater concentration of EOS compared to all other treatment 
and sampling d combinations.  Also, a treatment × day tendency (P = 0.09) indicated that CON 
and OXF-treated on d 14 tended to have the greatest proportions of BAS compared with all on 
other treatment and sampling day combinations (data not shown).   
Calf performance, fecal egg counts, and complete blood cell counts 
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 Starting on d 146, calves from dams who had been treated with OXF tended (P = 0.10) to 
have greater BW compared to calves from dams who had been treated with LAE, but BW did not 
differ (P = 0.77) for CON calves compared to calves whom dams were treated (Table 11).  On d 
228, average weaning weights (WW) were 239, 252, and 235 kg for CON, OXF, and LAE, 
respectively. Calf WW on d 228 was greater (P = 0.03) from OXF calves compared to LAE 
calves; however, WW did not differ (P = 0.52) from CON calves compared to calves from dams 
that were treated with an anthelmintic.  At weaning (d 228), calves were administered the same 
anthelmintic that their dams received.  Following anthelmintic administration, calf BW was 
increased in OXF- and LAE-treated calves.  Calf BW on d 242 and 327 (14 and 98 post-
treatment, respectively) tended (P ≤ 0.09) to be greater for OXF- and LAE- treated calves 
compared to calves that did not receive anthelmintic treatment.  Also, on d 417 (anthelmintics 
were re-administered) and 431 calf BW was greater (P ≤ 0.02) for treated calves compared to 
CON calves. Calve total gain was greater (P < 0.01) from treated calves compared to CON 
calves, and tended (P = 0.06) to be greater for LAE-treated calves compared with OXF.  Calf 
ADG was greater (P ≤ 0.01) on d 228 to 242 and 417 to 431 for treated calves compared to CON 
calves.  Also, on d 228 to 242 calf ADG was greater (P < 0.01) for LAE-treated calves compared 
to OXF-treated calves; however, ADG was the inverse of that on d 417 to 431, where OXF-
treated calves had greater (P < 0.01) ADG compared to LAE-treated calves.  Anthelmintic 
treatment did not positively impact ADG from d 242 to 327, with all treatments having similar 
(P = 0.30) ADG.  Oxfendazole- and LAE-treated calves tended (P = 0.08) to have greater ADG 
compared to CON, and LAE had greater (P = 0.01) ADG compared OXF from d 327 to 417.  
Furthermore, overall ADG was greater (P < 0.01) for treated calves compared to CON calves, 
and treatment with LAE tended (P = 0.06) to increase ADG compared to OXF administration.  
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Overall calf ADG (d 228 to 431) averaged 0.36, 0.42, and 0.47 kg/d for CON, OXF, and LAE, 
respectively.  These results agree with those reported by Walker et al. (2013), which indicated 
that cattle treated with an anthelmintic had greater performance compared to untreated cattle.  In 
that study, weaned fall-born steers and heifers were allocated to 1 of 5 treatments consisting of: 
1) oral oxfendazole given on d 0 followed by moxidectin on d 73; 2) moxidectin on d 0 and oral 
oxfendazole on d 73; 3) moxidectin given on d 0; 4) oxfendazole on d 0; 5) control, and were 
followed for a 108 d post-treatment grazing period.  Treated cattle had greater overall ADG and 
greater BW on d 31, 59, and 108 of the study compared to CON cattle.  Similar differences were 
not reported for BCS or HCS, with respected measurements not differing on any collection day.   
 The effects of anthelmintic administration on FEC in calves are outlined in Table 12 and 
followed a similar pattern as reported by their dams.  However, as to be expected, calves 
averaged a higher FEC compared with their dams over a 203 d grazing period.  For the duration 
of the grazing period, CON calves had greater (P < 0.01) FEC compared with treated calves, and 
LAE-treated calves exhibited greater (P < 0.01) FEC compared to OXF- treated calves.  Mean 
FEC averaged, 64, 17, and 28 eggs/g for CON, OXF, and LAE calves respectively.  A treatment 
× day interaction was detected (P < 0.01) for FEC.  Fecal egg counts were greatest on d 327 
(which was 99 d post-weaning and anthelmintic administration) for CON calves compared to all 
other treatment and day combinations, with FEC reaching 306 eggs/g.  The second highest FEC 
was reported by OXF-treated calves on d 327, averaging 200 eggs/g.  The lowest FEC over the 
203 d grazing period was reported by OXF-treated cows on d 242 and 431, with mean FEC 
decreasing to 2 and 3 eggs/g.  The decreases in FEC reported in the OXF-treated calves 14 d 
post-anthelmintic treatment followed a similar pattern as depicted by their dams.  In regards to 
the LAE-treated calves, 14-d post treatment, FEC did not decrease.  Furthermore, 99-d post 
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treatment FEC for LAE reached their highest values over the duration of the study.  According to 
Forbes (2013), blood plasma concentrations of LAE release a second wave into the body near d 
90, theoretically resulting in a decrease in FEC; however, this was not the case.  The results of 
the current study could indicate possible anthelmintic resistance occurring in cattle treated with 
LAE; however, further research is warranted to evaluate these discrepancies.    
 The concentrations of calf NEU, MON, EOS, BAS, and the N:L did not differ (P ≥ 0.24) 
across treatments (Table 13).  However, concentrations of WBC, LYM, and RBC were greater 
(P ≤ 0.02) for OXF-treated calves compared with LAE-treated calves; however, did not differ (P 
≥ 0.26) from CON compared to treated calves.  Lastly, PLT were greater (P = 0.01) for CON 
compared with treated, also OXF-treated calves had greater (P = 0.05) PLT compared to LAE-
treated calves.  Neutrophils were greatest on d 417 for CON calves and lowest for CON calves 
on d 327 as depicted by the treatment × day interaction (P = 0.01; data not shown).     
Heifer performance, reproductive measurements, and complete blood cell counts 
 Heifer BW on d 522, 559 (at pregnancy check), ADG from d 522 to 559, BCS and FEC 
on d 522 did not differ (P ≥ 0.21) across treatments (Table 14).  Similarly, pregnancy rate and 
calving rate (percentage of cows that calved/cow exposed) did not differ (P ≥ 0.32) between 
treatments.  Pregnancy rates were 79, 85, and 94 % and calving rates were 79, 85, and 87% for 
CON, OXF, and LAE heifers, respectively.  Similar calving rates were reported by Purvis et al. 
(1994), indicating that calving rates were not increased in spring-born heifers administered OXF 
intrarumminally compared to heifers not receiving OXF.  Birth weights from calves born from 
study heifers did not differ (P = 0.99) across treatments and averaged 34 to 36 kg.   
Anthelmintic administration did not impact (P ≥ 0.20) concentrations of LYM, N:L, 
MON, EOS, BAS, and PLT on d 522.  Concentrations of WBC were greater (P = 0.05) and RBC 
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were greater (P = 0.04) for OXF-treated heifers compared to LAE-treated heifers; however, were 
similar (P ≥ 0.13) from CON and treated calves.  Similar results were reported for concentrations 
of NEU, where LAE tended (P = 0.07) to be lower compared to OXF, but did not differ (P = 
0.78) across CON heifers compared to treated heifers.   
Steer carcass measurements 
 Steer carcass HCW, marbling, and 12th rib fat thickness (FT) were similar (P ≥ 0. 45) 
across anthelmintic regimens (Table 15).  Kidney, pelvic, and heart fat percentage was similar (P 
= 0.69) for carcasses from CON compared to treated calves; however, tended (P = 0.06) to be 
greater in carcasses of OXF-treated compared to LAE-treated steers.  Longissimus muscle area 
(LMA) was greater (P = 0.02) and yield grade (YG) was lower (P = 0.02) for carcasses from 
CON steers compared to treated steers; however, LMA and YG did not differ (P ≥ 0.81) between 
OXF- and LAE-treated steers.  Although, LMA and YG differed between CON and treated 
steers, the percentage of carcasses that graded Choice and Select did not differ (P = 0.63); 
likewise, percentages did not differ (P = 0.71) between OXF- and LAE-treated steers.  
Percentages of carcasses that graded Select were 38, 43, and 50% and percentages of carcasses 
that graded Choice was 62, 57, and 50% for CON, OXF, and LAE, respectively.  Carcass quality 
measurements in the current study disagree with previous work completed by Ballweber et al. 
(2000) and MacGregor et al. (2001) who utilized various anthelmintic treatments in feeder steers.  
Ballweber et al. (2000) evaluated the effects of fenbendazole plus topical fenthion treatment at 
the initiation of the grazing season and prior to the entry of feedyard and ivermectin-sustained 
released bolus at the beginning of the grazing season and compared them to a negative control.  
It was reported that carcasses from treated cattle had greater HCW, and lower YG compared to 
carcasses from control cattle.  Secondly, MacGregor et al. (2001) reported that quality grade was 
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improved in carcasses from steers fed to finish after administration of doramectin upon arrival to 
the feed yard.  There was a 5% increase in carcasses that graded choice compared to a 5% 
decrease in carcasses that graded select.  Also, as to be expected, FT was not improved in cattle 
administered anthelmintic treatments, due to the cattle being fed to a desired level of finish.  
However, in the present study, cattle that were not administered an anthelmintic had a greater 
LMA and lower YG, therefore due to no differences being reported for quality grade, the 
monetary value associated with the decrease in yield grade may not be positively impacted. 
Conclusion 
 To our knowledge, this is one of the only studies that compares the effects of 
administration of long-acting eprinomectin, oxfendazole and a negative control evaluating 
progeny gain performance, reproductive measurements, and complete blood cell counts, as well 
as carcass performance.  From this study, cows treated with an anthelmintic exhibited improved 
ADG compared to controls; however, reproductive performance was not improved.  Also, calves 
born from dams that received no anthelmintic had decreased performance post-weaning, and 
increased overall FEC during the grazing period; however, these factors did not affect carcass 
measurements.  Therefore, anthelmintic administration exhibited benefits in calf gain 
performance; however, it did not impact reproductive performance or carcass measurements. 
Results indicate that in a rotational grazing system, administration of long-acting eprinomectin 
compared to oral oxfendazole and a negative control may not increase overall cow reproductive 
performance, but may improve cow ADG and post-weaning calf gain. 
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Table 7. Performance Measurements of Spring-Calving Cows Treated Prior to Calving With Either Oxfendazole or 
Long-Acting Eprinomectin 
 Treatmentsa     
Item CON OXF LAE SEMb P-Valuec CON vs 
TREATED 
OXF vs 
LAE 
BW, kg        
        
d 0 574 561 554 14.2 0.57 0.33 0.69 
d 14 604 573 570 14.8 0.20 0.07 0.88 
d 91 557 551 530 14.8 0.41 0.37 0.32 
d 146 570 554 557 15.2 0.71 0.42 0.86 
d 228 567 574 572 14.7 0.96 0.81 0.93 
Total gain, kg 0.09 12.27 18.13 6.800 0.17 0.07 0.54 
ADG, kg/d        
d 0 to 14 1.88 0.94 1.29 0.36 0.13 0.05 0.44 
d 14 to 91 -0.57y -0.33x -0.51xy 0.078 0.07 0.09 0.08 
d 91 to 146 0.25g 0.06h 0.50f 0.067 <0.01 0.75 <0.01 
d 146 to 228 -0.01g 0.23f 0.18f 0.110 <0.01 <0.01 0.38 
Overall 0.00 0.05 0.08 0.030 0.17 0.07 0.54 
BCSd        
d 0 5.6 5.7 5.6 0.09 0.89 0.95 0.63 
d 14 5.8 5.9 5.8 0.059 0.25 0.96 0.10 
d 91 5.8fg 5.9f 5.7g 0.06 0.04 0.96 0.01 
d 146 5.9 5.9 5.9 0.04 0.36 0.92 0.15 
   d 228 5.8 5.7 5.7 0.11 0.68 0.39 0.86 
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Table 7. Performance Measurements of Spring-Calving Cows Treated Prior to Calving With Either Oxfendazole or 
Long-Acting Eprinomectin (Cont.)  
 Treatmentsa     
Item CON OXF LAE SEMb P-Valuec CON vs 
TREATED 
OXF vs 
LAE 
HCSe        
d 0 4.9 5.0 4.9 0.03 0.61 0.60 0.40 
d 91 2.8f 1.7g 3.5f 0.24 <0.01 0.39 <0.01 
d 146 2.7 2.6 3.0 0.24 0.63 0.70 0.38 
Pregnancy Rate, % 77 81 61 -- 0.18 0.59 0.08 
a CON = control; OXF = oxfendazole; and LAE = long-acting eprinomectin. 
b SEM = pooled 
SEM. 
       
c Cow BW, ADG, total gain, BCS, and HCS were analyzed using PROC MIXED; Pregnancy Rate was analyzed using 
GENMOD. 
d 1 to 9 scale; 1 = emaciated; 9 = obese; (Wagner et al., 1988). 
e HCS = hair coat score; 1 to 5 scale; 1 = slick, summer coat; 5 = full winter hair coat; (Gray et al., 2011). 
f-h Means within a row without common superscript differ (P ≤ 0.05). 
x-y Means within a row without common superscript tended (P ≤ 0.10) to differ. 
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Table 8. Fecal Egg Count (Geometric Means; GM) Treatment × Day Interaction of Spring-Calving Cows Treated Prior to 
Calving With Either Oxfendazole or Long-Acting Eprinomectin  
 Treatmentsa     
Item CON OXF LAE SEMb P-Value CON vs 
TREATED 
OXF vs 
LAE 
FEC, GMc 2.4d 1.5e 2.1d 0.03 <0.01 <0.01 <0.01 
d 0 2.6gh 2.5gh 2.8gh --    
d 14 2.9g 1.0i 1.2i --    
d 91 1.5hi 1.1i 1.6hi --    
d 146 2.5gh 1.5hi 1.4hi --    
d 228 2.4gh 1.9h 5.5f --    
a CON = control; OXF = oxfendazole; and LAE = long-acting eprinomectin. 
b SEM = pooled SEM. 
c FEC = fecal egg counts. 
d-e Means within a row without common superscript differ (P ≤ 0.05). 
f-i Means without common superscript differ (P < 0.05). 
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Table 9. Complete Blood Cell Counts of Spring-Calving Cows Treated Prior to Calving With Either Oxfendazole or Long-
Acting Eprinomectin Over the 228 d Grazing Period 
 Treatmentsa     
Item CON OXF LAE SEMb P-Value CON vs 
TREATED 
OXF vs 
LAE 
White blood cells K/µL 6.6c 6.6c 6.1d 0.07 <0.01 0.04 <0.01 
Neutrophils, K/µL 2.08x 2.01y 2.22x 0.067 0.08 0.67 0.02 
Lymphocytes, K/µL 3.195c 3.197c 2.745d 0.1038 <0.01 0.08 <0.01 
Neutrophil:Lymphocyte 0.87d 0.85d 1.17c 0.062 <0.01 0.06 <0.01 
Monocytes, K/µL 0.7 0.7 0.7 0.06 0.30 0.99 0.12 
Eosinophils, K/µL 0.5c 0.6c 0.3d 0.03 <0.01 0.01 <0.01 
Basophils, K/µL 0.086 0.094 0.080 0.0166 0.18 0.83 0.06 
Red blood cells, M/µL 6.8 6.6 6.7 0.10 0.30 0.14 0.61 
Platelets, K/µL 205 193 197 30.5 0.70 0.42 0.77 
a CON = control; OXF = oxfendazole; and LAE = long-acting eprinomectin. 
b SEM = pooled SEM. 
c-e Means within a row without common superscript differ (P ≤ 0.05). 
x-y Means within a row without common superscript tended (P ≤ 0.10) to differ. 
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Table 10. Treatment × Day Interaction on Blood Parameters of Spring-Calving Cows 
Treated Prior to Calving With Either Oxfendazole or Long-Acting Eprinomectin  
 Treatmentsa 
Item CON OXF LAE 
White blood cell, K/µL    
d 0 7.11bc 6.99c 6.63c 
d 14 7.78b 7.48bc 7.58bc 
d 91 5.70d 6.37cd 5.58d 
d 146 6.81c 6.89c 5.46d 
d 228 5.68d 5.23d 5.19d 
Neutrophil, K/µL    
d 0 2.6b 2.4bc 2.5b 
d 14 1.3d 1.2d 1.8c 
d 91 2.2c 2.0c 2.6b 
d 146 2.6b 2.6b 2.2bc 
d 228 1.7cd 1.9c 1.9c 
Neutrophil:Lymphocyte    
d 0 0.8de 0.8de 0.8de 
d 14 0.3d 0.3d 0.5d 
d 91 1.4c 1.0d 2.2b 
d 146 1.1cd 1.1cd 1.1cd 
d 228 0.7de 1.0d 1.2cd 
Eosinophils, K/µL    
d 0 0.44d 0.47d 0.39de 
d 14 0.34de 0.27e 0.20e 
d 91 0.68c 1.0b 0.43de 
d 146 0.64cd 0.71c 0.23e 
d 228 0.66c 0.56cd 0.44d 
a CON = control; OXF = oxfendazole; and LAE = long-acting eprinomectin. 
b-e Means within a row without common superscript differ (P ≤ 0.05). 
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Table 11. Post-Weaning Performance Measurements of Spring-Born Calves Treated With Either Oxfendazole or Long-
Acting Eprinomectin At Weaning and 189 d Post-Weaning 
 Treatmentsa     
Item CON OXF LAE SEMb P-Valuec CON vs 
TREATED 
OXF vs 
LAE 
BW, kg        
d 91 108 110 104 4.5 0.38 0.84 0.18 
d 146 164 170 161 5.9 0.26 0.77 0.10 
d 228 (weaning) 239xy 252x 235y 7.4 0.09 0.52 0.03 
d 242 235 250 245 7.7 0.13 0.06 0.46 
d 327 254xy 272x 260xy 8.7 0.09 0.09 0.16 
d 417 (retreat) 296xy 315x 312xy 10.6 0.08 0.02 0.68 
d 431 313f 339e 330ef 12.3 0.01 <0.01 0.29 
Total Gain 73 86 95 7.8 <0.01 <0.01 0.06 
ADG, kg/d        
d 228 to 242 -0.31f -0.12f 0.64e 0.125 <0.01 <0.01 <0.01 
d 242 to 327 0.23 0.24 0.18 0.040 0.30 0.67 0.13 
d 327 to 417 0.47f 0.47f 0.56e 0.030 <0.01 0.08 0.01 
d 417 to 431 1.13f 1.65e 1.30f 0.120 <0.01 <0.01 <0.01 
Overall 0.36f 0.42e 0.47e 0.038 <0.01 <0.01 0.06 
BCSd        
d 228 6 6 6 0.0 1.00 1.00 1.00 
d 242 6 6 6 0.0 1.00 1.00 1.00 
d 327 6 6 6 0.0 1.00 1.00 1.00 
d 417 7 7 7 0.0 1.00 1.00 1.00 
d 431 7 7 7 0.0 1.00 1.00 1.00 
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Table 11. Post-Weaning Performance Measurements of Spring-Born Calves Treated With Either Oxfendazole or 
Long-Acting Eprinomectin At Weaning and 189 d Post-Weaning (Cont.) 
 Treatmentsa     
Item CON OXF LAE SEMb P-Valuec CON vs 
TREATED 
OXF vs 
LAE 
HCSe        
d 417 5 5 5 1.1 0.38 0.48 0.23 
d 431 5 5 5 0.1 0.35 0.92 0.15 
a CON = control; OXF = oxfendazole; and LAE = long-acting eprinomectin. 
b SEM = pooled 
SEM. 
       
c 1 to 9 scale; 1 = emaciated; 9 = obese; (Wagner et al., 1988). 
d HCS = hair coat score; 1 to 5 scale; 1 = slick, summer coat; 5 = full winter hair coat; (Gray et al., 2011). 
e-g Means within a row without common superscript differ (P ≤ 0.05). 
x-y Means within a row without common superscript tended (P ≤ 0.10) to differ. 
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Table 12. Fecal Egg Count (Geometric Means; GM) Treatment × Day Interaction of Spring-Born Calves Treated With 
Either Oxfendazole or Long-Acting Eprinomectin At Weaning and 189 d Post-Weaning 
 Treatmentsa     
Item CON OXF LAE SEMb P-Value CON vs 
TREATED 
OXF vs 
LAE 
FEC, GMc 64.0d 16.9f 27.8e 0.04 <0.01 <0.01 <0.01 
d 228 (weaning) 49j 20kl 21kl     
d 242 88i 2m 13l     
d 327 306g 200h 64ij     
d 417 (retreat) 22k 45j 42j     
d 431 36j 3m 24k     
a CON = control; OXF = oxfendazole; and LAE = long-acting eprinomectin. 
b SEM = pooled SEM. 
c FEC = fecal egg counts. 
d-f Means within a row without common superscript differ (P ≤ 0.05). 
g-m Means without common superscript differ (P ≤ 0.05). 
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Table 13. Complete Blood Cell Counts of Spring-Born Calves Treated With Either Oxfendazole or Long-Acting 
Eprinomectin At Weaning and 189 d Post-Weaning 
 Treatmentsa     
Item CON OXF LAE SEMb P-Value CON vs 
TREATED 
OXF vs 
LAE 
White blood cells K/µL 8.9c 9.2c 7.9d 0.26 <0.01 0.26 <0.01 
Neutrophils, K/µL 1.9 1.8 1.8 0.06 0.24 0.32 0.18 
Lymphocytes, K/µL 5.97c 6.32c 5.15d 0.254 <0.01 0.46 <0.01 
Neutrophil:Lymphocyte 1.38 1.73 1.36 0.194 0.31 0.49 0.16 
Monocytes, K/µL 0.88 0.83 0.81 0.038 0.40 0.21 0.61 
Eosinophils, K/µL 0.14 0.14 0.13 0.017 0.61 0.60 0.40 
Basophils, K/µL 0.06 0.06 0.06 0.005 0.57 0.70 0.33 
Red blood cells, M/µL 9.8c 9.9c 9.6d 0.15 0.04 0.31 0.02 
Platelets, K/µL 662c 626e 563d 22.8 <0.01 0.01 0.05 
a CON = control; OXF = oxfendazole; and LAE = long-acting eprinomectin. 
b SEM = pooled SEM. 
c-e Means within a row without common superscript differ (P ≤ 0.05). 
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Table 14. Performance of Spring-Born Heifer Calves Treated With Either Oxfendazole or Long-Acting Eprinomectin At 
Weaning and 189 d Post-Weaning 
 Treatmentsa     
Item CON OXF LAE SEMb P-Valuec CON vs 
TREATED 
OXF vs 
LAE 
BW, kg         
d 522 359 377 380 10.0 0.27 0.11 0.80 
d 559 372 388 387 9.9 0.44 0.20 0.93 
ADG, kg/d     0.09 0.52 0.03 
d 522 to 559 0.36 0.31 0.19 0.070 0.21 0.22 0.23 
BCSd     0.09 0.09 0.16 
d 552 7 7 7 1.0 1.00 1.00 1.00 
Fecal egg counts, GM     0.01 <0.01 0.29 
d 522 6 11 9 0.1 0.50 0.27 0.64 
Pregnancy rate, % 79 85 94 -- 0.45 0.32 0.42 
Calving rate, % 79 85 87 -- 0.39 0.53 0.82 
Calf birth weight, kg 34 36 34 25 0.99 0.99 0.95 
Complete blood cell counts, d 522 
White blood cells, K/µL 6.9y 8.2x 7.2y 0.37 0.06 0.13 0.05 
Neutrophils, K/µL 2.6 2.9 2.4 0.02 0.20 0.78 0.07 
Lymphocytes, K/µL 3.4 4.5 3.5 0.39 0.14 0.20 0.11 
Neutrophil:Lymphocyte 0.9 0.7 0.8 0.36 0.52 0.39 0.43 
Monocytes, K/µL 0.7 0.7 0.7 0.07 0.85 0.66 0.75 
Eosinophils, K/µL 0.4 0.2 0.4 0.07 0.19 0.24 0.14 
Basophils, K/µL 0.1 0.1 0.1 0.02 0.33 0.14 0.71 
Red blood cells, M/µL 8.9x 8.9x 7.5y 0.50 0.06 0.23 0.04 
Platelets, K/µL 199 222 162 34.9 0.47 0.87 0.23 
a CON = control; OXF = oxfendazole; and LAE = long-acting eprinomectin. 
b SEM = pooled SEM.        
c Heifer BW, ADG, BCS, Fecal egg counts, complete blood cell counts, and calf birth weights were analyzed using PROC 
MIXED; Pregnancy and calving rates were analyzed using GENMOD. 
d 1 to 9 scale; 1 = emaciated; 9 = obese; (Wagner et al., 1988). 
x-y Means within a row without common superscript tended (P ≤ 0.10) to differ. 
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Table 15. Carcass Measurements By Spring-Born Calves Treated With Either Oxfendazole or Long-Acting 
Eprinomectin At Weaning and 189 d Post-Weaning 
 Treatmentsa     
Item CON OXF LAE SEMb P-Valuec CON vs 
TREATED 
OXF vs 
LAE 
HCW, kg  404 420 411 9.1 0.45 0.30 0.49 
Marbling 310 307 312 10.1 0.92 0.96 0.70 
12th rib fat thickness, 
cm 
1.4 1.5 1.5 0.09 0.78 0.65 0.57 
Longissimus muscle 
area, cm2 
104x 96y 95y 3.1 0.08 0.02 0.81 
KPH, % 2.1 2.1 1.9 0.11 0.15 0.69 0.06 
Yield Grade 2.5y  3.1x 3.1x 0.20 0.07 0.02 0.96 
Select, n (%)d 5 (38) 6 (43) 6 (50) --    
Choice, n (%)d 8 (62) 8 (57) 6 (50) --    
a CON = control; OXF = oxfendazole; and LAE = long-acting eprinomectin. 
b SEM = pooled SEM.        
c Percentage of carcasses that graded Choice and Select were determined using GENOMD; All other carcass measurements 
were analyzing using PROC MIXED. 
d Percentage of carcasses from CON steers compared to carcasses from treated steers that graded Choice or Select did not 
differ (P = 0.63); Percentage of carcasses from OXF-treated steers compared with carcasses from LAE-treated steers that 
graded Choice and Select did not differ (P = 0.71). 
x-y Means within a row without common superscript tended (P ≤ 0.10) to differ. 
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CONCLUSION 
 Based on the results in experiment 1, treatment with anthelmintics can improve heifer 
gain and reproductive performance.  Also, improvement in BW and ADG occurred and overall 
pregnancy rates tended to improve with LAE compared to MO-treated heifers. In experiment 2, 
the use of anthelmintics reported minimal differences in terms of gain performance in cows.  
However, post-weaning performance was improved when an anthelmintic was administered.  
Results of this study indicate that in a rotational grazing system, administration of long-acting 
eprinomectin compared to a conventional anthelmintic and negative control may not increase 
cow performance, but may improve post-weaning calf performance, without improving 
reproductive measurements or carcass quality.    
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